Factors influencing health status and contact with health services

Z21_FACTO_INFLUENCI_HEALTH_STATUS_CONTACT_W_HEALTH_SERVI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z00-ZZB Hospital discharge: ICD-9 — V Hospital discharge: ICD-8 — Y Cause of death: ICD-10 — Z00-ZZB Cause of death: ICD-9 — V Cause of death: ICD-8 — Y 2 out of 7 registries used, show all original rules.	440632
4. Check minimum number of events None	440632
5. Include endpoints None	440632
6. Filter based on genotype QC (FinnGen only)	395585

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 1
First used in FinnGen datafreeze: DF4

NAME	Z21_FACTO_INFLUENCI_HEALTH_STATUS_CONTACT_W_HEALTH_SERVI
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z
HD_ICD_9	V
HD_ICD_8	Y
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z
COD_ICD_9	V
COD_ICD_8	Y
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Factors influencing health status and contact with health services based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	395585	244395	151190
Unadjusted period prevalence (%)	80.10	86.77	69.33
Median age at first event (years)	43.43	35.55	56.17

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
21621: Matched controls
108514

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

ZXD05

NOMESCO Finland

Urgent procedure

2.0

319.3

4684

12932

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.3

318.8

3473

8501

WZC00

NOMESCO Finland

Treatment plan or consultation

1.9

318.2

5929

17834

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.9

316.5

2010

3754

L28

ICPC

Limited function/disability (L)

2.5

315.1

2642

5726

B01AB05

ATC

enoxaparin; parenteral

2.1

314.8

4404

11932

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

313.9

12887

49368

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

23.2

313.8

382

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

311.5

3985

10420

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.5

309.0

2689

5931

R53

ICD-10 Finland

Malaise and fatigue

2.1

309.0

4027

10604

Z50.1

ICD-10 Finland

Other physical therapy

22.2

307.7

650

151

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

25.1

307.7

776

161

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

9.9

307.7

1874

1034

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

19.1

307.7

1105

305

KFD46

NOMESCO Finland

Bilateral vasectomy or ligature of vas deferens

88.4

307.7

499

Z01.0

ICD-10 Finland

Examination of eyes and vision

15.3

307.7

2921

1096

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

4.3

307.7

1380

1702

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.2

307.7

4807

12426

Z01.1

ICD-10 Finland

Examination of ears and hearing

7.9

307.7

2255

1569

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.4

307.7

3611

8278

S18

ICPC

Laceration/cut

1.9

307.7

7713

24772

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

109.8

307.7

575

Z71.8

ICD-10 Finland

Other specified counselling

2.9

307.7

5502

11543

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

7.1

307.7

2894

2322

H02AB06

ATC

prednisolone; systemic

1.9

307.7

7943

25689

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

43.2

307.7

740

A02BC02

ATC

pantoprazole; systemic

2.2

307.7

12080

40208

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

307.7

8118

22082

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

202.5

307.7

435

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

17.4

307.7

556

164

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

8.0

307.7

801

518

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

17.0

307.7

786

240

N05AH04

ATC

quetiapine; oral

2.5

307.7

2881

6320

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

5.1

307.7

2027

2167

Z51.5

ICD-10 Finland

Palliative care

12.4

307.7

1188

508

Z01.8

ICD-10 Finland

Other specified special examinations

8.6

307.7

3841

2657

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

31.5

307.7

1428

243

R06.0

ICD-10 Finland

Dyspnoea

2.2

307.7

4136

10461

Z3231

NOMESCO Finland

Registered nurse

2.4

307.7

4357

10186

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

17.7

307.7

801

236

LGA21

NOMESCO Finland

Laparoscopic sterilisation by constriction of Fallopian tubes

154.3

307.7

333

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

50.2

307.7

846

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

71.4

307.7

622

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

+∞

307.7

584

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

11.4

307.7

942

433

Z30.2

ICD-10 Finland

Sterilization

34.7

307.7

1185

181

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.8

307.7

4534

9549

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

+∞

307.7

554

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

21.7

307.7

660

157

N06AX11

ATC

mirtazapine; oral

2.0

307.7

5470

15491

N02BE01

ATC

paracetamol; systemic, rectal

2.3

307.7

17076

66771

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

174.6

307.7

707

C03CA01

ATC

furosemide; systemic

2.1

307.7

4998

13801

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

83.6

307.7

615

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

20.9

307.7

484

119

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

824.6

307.7

930

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

99.0

307.7

1316

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

21.1

307.7

518

126

N02AA05

ATC

oxycodone; systemic

2.9

307.7

2772

5209

Z37.0

ICD-10 Finland

Single live birth

+∞

307.7

444

AA1AD

NOMESCO Finland

CT of head and brain

2.2

307.7

4527

11537

Z31.5

ICD-10 Finland

Genetic counselling

1394.7

307.7

552

Z96.1

ICD-10 Finland

Presence of intraocular lens

13.7

307.7

2233

903

N03AX16

ATC

[U] pregabalin

2.4

307.7

3286

7461

Z32.1

ICD-10 Finland

Pregnancy confirmed

17.7

307.7

504

146

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

307.7

5667

16294

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

307.7

2840

6275

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

64.0

307.7

1102

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

45.0

307.7

517

Z00.0

ICD-10 Finland

General medical examination

3.1

307.7

3153

5599

DFF00

NOMESCO Finland

Pure tone audiometry

4.7

307.7

1384

1566

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

307.7

4478

11710

N02AX02

ATC

tramadol; systemic, rectal

1.9

307.7

7223

22421

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

307.7

2658

5590

Z39.2

ICD-10 Finland

Routine postpartum follow-up

22.6

307.7

720

165

Z31.4

ICD-10 Finland

Procreative investigation and testing

27.8

307.7

397

J01DB01

ATC

cefalexin; oral

2.1

307.7

15725

60783

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

15.9

307.7

692

225

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

404.9

307.7

1146

Z97.4

ICD-10 Finland

Presence of external hearing-aid

450.1

307.7

695

C07AB07

ATC

bisoprolol; oral

2.0

307.7

8160

25550

1412

FHL

Laparoscopy and sterilization

59.2

307.7

394

UJF32

NOMESCO Finland

Coloscopy

2.5

307.7

3904

8869

W78

ICPC

Pregnancy

6.7

307.7

885

687

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

10.3

304.6

511

254

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

94.8

302.8

298

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

9.8

300.9

521

274

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

297.4

6807

21808

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

295.7

4617

12996

SPAT1380

SPAT

Postpartum check-up

11.4

290.0

462

208

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

14.0

289.6

419

153

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

288.4

7141

23392

Z3229

NOMESCO Finland

Other healthcare associate professional

3.7

288.3

1211

1719

SPAT1379

SPAT

Health check-up of pregnant person

7.9

287.6

567

367

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

639.9

287.6

376

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

286.1

7093

23230

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.1

283.9

3984

10758

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

9.0

280.3

509

290

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

58.6

280.0

288

N03AX12

ATC

[U] gabapentin; oral

2.6

279.7

2181

4542

RD211, ,

NOMESCO Finland

9.6

278.8

487

260

A02BC05

ATC

esomeprazole; systemic

1.8

278.2

6274

19921

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

276.4

5288

15919

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.3

275.9

2768

6502

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.2

275.5

1422

2331

SPAT1263

SPAT

Sampling

1.8

272.9

6532

21100

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

27.4

272.5

318

M79.6

ICD-10 Finland

Pain in limb

1.8

270.5

6884

22638

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

266.4

3795

10279

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

10.1

264.7

450

229

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

9.6

264.2

462

247

N05BA04

ATC

oxazepam; oral

2.0

264.1

3934

10830

AN1

Coronary angiography

3.0

262.1

1551

2768

A28

ICPC

Limited function/disability NOS

2.3

258.9

2483

5705

R03AC02

ATC

salbutamol; inhalant

1.7

258.5

9143

32887

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

30.5

257.9

294

DFF15

NOMESCO Finland

Speech audiometry

6.6

254.7

572

442

Z04.3

ICD-10 Finland

Examination and observation following other accident

68.4

253.1

256

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

252.8

12759

50297

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

251.7

3359

8857

XCK10

NOMESCO Finland

Photography of fundus of eye

3.3

251.5

1251

1998

SPAT1197

SPAT

Extensive health check-up of expecting family

5.1

251.0

719

731

ZXE00

NOMESCO Finland

One hour or less

1.8

250.8

5859

18692

M54.5

ICD-10 Finland

Low back pain

1.8

248.0

5703

18097

SPAT1216

SPAT

Assessment of functional ability

2.5

246.9

2022

4304

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

240.5

245.5

331

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

39.7

245.2

266

WX307

NOMESCO Finland

Obstetric epidural analgesia

10.5

244.4

406

198

H25.1

ICD-10 Finland

Senile nuclear cataract

1.9

243.9

3959

11205

J01MA02

ATC

ciprofloxacin; systemic

1.7

243.8

6385

21037

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

239.0

3721

10369

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

183.3

237.8

325

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

234.6

4576

13755

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

+∞

233.8

299

MA3AE

NOMESCO Finland

Combined first trimester screening

228.6

233.1

315

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.7

231.6

1638

3228

OAA11, ,

SPAT

12.5

231.3

352

144

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

231.2

5687

18343

A04

ICPC

Weakness/tiredness general

2.3

230.8

2337

5485

J01CA04

ATC

amoxicillin; systemic

1.7

229.4

15357

64320

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

228.9

4469

13423

N05CF01

ATC

zopiclone; oral

1.8

228.4

5054

15784

N06AX21

ATC

duloxetine; oral

2.7

227.1

1536

2953

Y6099

ICD-8 Finland

Prenatal care and observation

+∞

226.8

290

R42

ICD-10 Finland

Dizziness and giddiness

2.0

225.2

3293

8953

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

6.0

225.1

547

465

R51.80

ICD-10 Finland

Headache

2.3

224.4

2099

4751

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

222.2

6423

21639

SPAT1153

SPAT

Removal of sutures

1.8

221.4

4480

13591

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

221.1

2027

4544

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

219.8

1860

4014

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

218.1

1814

3881

R5120

NOMESCO Finland

Preparation of an aid

10.1

217.8

368

185

SPAT1301

SPAT

No procedures

1.8

216.3

4604

14175

XQ800

NOMESCO Finland

Prick test

4.0

216.0

816

1063

I50.9

ICD-10 Finland

Heart failure, unspecified

2.2

216.0

2268

5400

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

215.6

9105

33770

B01AC04

ATC

clopidogrel; oral

2.2

215.3

2367

5747

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

215.0

5386

17400

L03

ICPC

Low back symptom/complaint

1.8

212.2

4249

12825

O80.0

ICD-10 Finland

Spontaneous vertex delivery

2.8

211.5

1390

2627

R4110

NOMESCO Finland

Physiotherapy

1.8

211.4

4114

12304

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

211.1

1932

4324

-1, ,

NOMESCO Finland

1.7

210.3

5324

17234

G47.3

ICD-10 Finland

Sleep apnoea

1.9

209.7

3829

11214

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

208.8

3414

9633

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.7

208.4

5054

16151

WZC30

NOMESCO Finland

Teaching

2.2

206.9

2307

5629

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

7.3

206.0

431

303

XF402

NOMESCO Finland

ECG with work load test

2.8

205.9

1335

2503

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

205.8

5704

18917

R5140

NOMESCO Finland

Monitoring the use of the aid

2.4

204.2

1725

3714

J01AA02

ATC

doxycycline; systemic

1.6

203.0

13713

56555

ZX120

NOMESCO Finland

Intravenous

2.9

202.9

1191

2107

L17

ICPC

Foot/toe symptom/complaint

1.8

202.4

4535

14141

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

202.2

2114

5017

Z00.8

ICD-10 Finland

Other general examinations

3.1

201.8

1085

1818

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

201.8

8911

33237

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

201.4

3684

10781

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

201.3

2905

7833

I49.5

ICD-10 Finland

Sick sinus syndrome

6.3

200.7

470

382

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

200.0

3651

10675

ZXA00

NOMESCO Finland

Right side

1.8

199.9

3844

11429

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

197.5

2914

7916

H26.4

ICD-10 Finland

After-cataract

2.8

197.5

1259

2337

Z3226

NOMESCO Finland

Physiotherapist

2.1

196.5

2545

6586

MAX99

NOMESCO Finland

Assistance to normal delivery

7.0

195.7

422

309

R50.9

ICD-10 Finland

Fever, unspecified

2.1

195.3

2344

5886

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

195.0

4444

13906

O99.80

ICD-10 Finland

The fear of childbirth

18.0

194.1

255

UKC02

NOMESCO Finland

Cystoscopy

2.1

194.0

2435

6223

N06AX16

ATC

venlafaxine; oral

2.3

193.9

1890

4346

XF404

NOMESCO Finland

Ambulatory ECG

3.0

193.4

1097

1900

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

192.6

2421

6190

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.9

191.0

1139

2033

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

190.3

2651

7045

M25.5

ICD-10 Finland

Pain in joint

1.7

189.5

4894

15856

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

6.6

189.2

425

328

KMAK, ,

NOMESCO Finland

1.6

189.2

8116

29926

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

3.0

188.8

1087

1899

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

2.6

188.8

1399

2817

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

188.7

1464

3018

CJB10

NOMESCO Finland

Laser discission of secondary cataract

3.1

188.1

1003

1671

OAA12, ,

SPAT

19.6

188.0

240

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

186.9

7467

27051

SPAT1254

SPAT

Administration of medicine

2.1

186.8

2178

5400

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

186.8

4491

14250

ZXA05

NOMESCO Finland

Left side

1.8

186.1

3546

10487

UJF30

NOMESCO Finland

Ileoscopy through colon

2.6

185.9

1350

2689

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

184.8

11594

46515

J01MA12

ATC

levofloxacin; systemic

2.0

183.8

2747

7483

A10AB05

ATC

insulin aspart; parenteral

2.9

183.6

1080

1911

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

182.8

1099

1970

WX320

NOMESCO Finland

Spinalanesthesy

1.8

182.0

3354

9806

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

181.4

6138

21314

B01AA03

ATC

warfarin; systemic

1.9

181.1

2978

8384

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

48.1

180.3

190

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

180.0

2887

8057

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

179.9

1396

2876

K02.1

ICD-10 Finland

Caries of dentine

1.5

179.5

10196

39911

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

11.6

179.0

282

124

Z2221

NOMESCO Finland

Medical doctor

1.8

178.3

3804

11634

A10AE04

ATC

insulin glargine; parenteral

2.5

177.3

1382

2853

WX002

NOMESCO Finland

Sedation and analgesia

2.0

176.9

2561

6890

P01AB01

ATC

metronidazole; oral, rectal

1.6

176.8

5653

19327

Z3232

NOMESCO Finland

Midwife

7.3

176.1

366

255

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

176.0

10157

39833

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.8

174.7

1113

2062

XMA22

NOMESCO Finland

General examination of pregnant woman

11.8

173.6

271

117

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.9

173.4

672

892

OAA10, ,

SPAT

11.1

173.1

278

127

WX290

NOMESCO Finland

Other blockage of nerve

1.5

170.9

8090

30308

N06AB10

ATC

escitalopram; oral

1.9

170.7

2947

8420

JN4AD

NOMESCO Finland

Body CT examination

2.4

170.4

1494

3265

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

169.9

3559

10808

C10AA01

ATC

simvastatin; oral

1.6

169.3

6307

22343

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

37.5

168.9

185

I44.2

ICD-10 Finland

Atrioventricular block, complete

6.6

166.9

373

286

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

4.1

166.6

606

764

R02

ICPC

Shortness of breath/dyspnoea

2.2

165.0

1763

4206

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

164.9

1767

4221

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

164.8

1724

4077

A02BC03

ATC

lansoprazole; oral

1.7

164.6

4152

13290

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.2

163.5

817

1303

E0000UV, ,

ATC

1.6

163.4

6571

23658

J01FF01

ATC

clindamycin; systemic

1.7

163.1

4063

12957

SPAT1262

SPAT

Handing over of treatment supplies

2.0

161.7

2359

6351

SFA10

NOMESCO Finland

One-surface restoration

1.5

161.4

9209

35786

ZXA10

NOMESCO Finland

Bilateral

1.9

160.7

2473

6784

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

40.0

160.6

174

C09AA05

ATC

ramipril; oral

1.7

160.4

3815

12002

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

159.8

2064

5311

J01DA01

ATC

[U] cefalexin

1.5

159.6

10669

42817

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

158.7

1250

2591

SPAT1310

SPAT

Counselling related to known health issue

1.7

157.9

4514

14922

ZY010

NOMESCO Finland

Hospital outpatient

3.6

157.8

669

951

N06AB04

ATC

citalopram; systemic

1.8

157.6

2896

8426

H25.8

ICD-10 Finland

Other senile cataract

2.4

156.8

1381

3021

A29

ICPC

General symptom/complaint other

2.1

156.0

1818

4492

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

155.8

2350

6397

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

154.2

2445

6771

C01DA14

ATC

isosorbide mononitrate; oral

1.9

154.2

2443

6764

G04CA02

ATC

tamsulosin; oral

1.7

153.8

4312

14168

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

152.3

1508

3478

SFA20

NOMESCO Finland

Two-surface restoration

1.5

152.0

9766

38726

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

150.4

2106

5579

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

3.6

150.1

631

891

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

150.0

3023

9041

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

8.8

149.7

274

158

C10AA05

ATC

atorvastatin; oral

1.5

149.4

6531

23854

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

149.2

2546

7222

R05

ICPC

Cough

1.7

148.8

3482

10878

M03BX02

ATC

tizanidine; oral

1.5

148.7

10144

40646

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

148.5

1050

2057

T90

ICPC

Diabetes non-insulin dependent

1.7

148.4

3501

10961

R01AD09

ATC

mometasone; nasal

1.5

148.2

6972

25865

W85

ICPC

Gestational diabetes

20.1

147.7

187

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

147.6

2840

8369

A02BC01

ATC

omeprazole; systemic

1.7

147.3

3914

12660

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

8.3

146.9

280

172

DAX08

NOMESCO Finland

Fitting of hearing aid

3.4

146.7

682

1035

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

37.0

146.7

161

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

146.4

1427

3267

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

18.2

146.2

191

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.9

145.8

555

726

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.2

145.5

1539

3649

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

145.5

1818

4611

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

144.8

2837

8403

A06AD11

ATC

lactulose; oral

1.9

144.3

2220

6076

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

144.1

1220

2617

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

143.6

3687

11807

Z01.2

ICD-10 Finland

Dental examination

1.5

143.5

7372

27816

XCH00

NOMESCO Finland

Eye pressure measurement

4.0

143.1

536

692

A01

ICPC

Pain general/multiple sites

2.4

142.9

1278

2813

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.8

142.6

282

183

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

7.3

142.2

295

205

C08CA01

ATC

amlodipine; oral

1.5

141.4

5879

21178

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

141.0

836

1483

M48.0

ICD-10 Finland

Spinal stenosis

2.1

139.5

1581

3856

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

139.2

1501

3586

R06AE07

ATC

cetirizine; oral

1.5

138.9

6678

24806

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

138.9

4260

14274

Z2446

NOMESCO Finland

Social worker

2.8

138.6

878

1618

N03AX09

ATC

lamotrigine; oral

3.6

138.4

591

844

R5110, ,

SPAT

2.6

137.5

981

1930

127

Kela drug reimbursment

Transplant complication

109.2

137.1

194

R11

ICD-10 Finland

Nausea and vomiting

2.4

136.9

1130

2393

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.1

135.9

726

1208

Z34

ICD-10 Finland

Supervision of normal pregnancy

18.3

135.6

177

S06.0

ICD-10 Finland

Concussion

2.1

135.4

1628

4064

R13

ICD-10 Finland

Dysphagia

2.7

134.4

884

1664

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.4

134.0

608

907

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

133.2

8333

32578

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.9

133.1

2211

6202

Y0599

ICD-8 Finland

Investigation of digestive system

+∞

132.8

170

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

132.6

1507

3677

XCK00

NOMESCO Finland

Perimetry

3.1

132.3

698

1152

N06AB06

ATC

sertraline; oral

2.1

131.9

1524

3743

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

131.8

1845

4875

L04AA06

ATC

mycophenolic acid; systemic

10.6

131.8

217

104

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

131.5

1891

5045

XA402

NOMESCO Finland

ENMG

8.3

131.5

250

153

Z01.9

ICD-10 Finland

Special examination, unspecified

3.0

131.3

742

1278

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

131.1

2451

7140

Z2445

NOMESCO Finland

Psychologist

3.9

130.8

497

649

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.7

130.6

874

1660

M01AH05

ATC

etoricoxib; oral

1.4

130.5

10289

41980

R4110, ,

SPAT

2.1

130.0

1627

4122

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

129.2

1716

4446

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.5

129.2

1043

2184

B03XA02

ATC

darbepoetin alfa; parenteral

8.1

128.7

248

155

XKD00

NOMESCO Finland

Uroflowmetry

1.8

128.6

2426

7084

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

127.9

1292

2999

A98

ICPC

Health maint/preventive medicine

1.7

127.7

18783

86622

J02AC01

ATC

fluconazole; systemic

1.6

127.4

4666

16265

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

126.2

1473

3630

XQ802

NOMESCO Finland

Epicutan test

4.9

126.1

367

378

XG410

NOMESCO Finland

Flow-volume spirometry

4.0

126.1

460

581

SPAT1252

SPAT

Overall medication plan or its review

2.8

125.5

792

1456

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.7

125.0

856

1646

A46

ICD-10 Finland

Erysipelas

1.8

124.9

2222

6365

W84

ICPC

Pregnancy high risk

20.3

124.5

157

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.0

123.9

698

1200

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.3

123.8

1155

2588

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.7

123.7

509

707

N05AH03

ATC

olanzapine; systemic

2.6

123.6

904

1800

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

4.2

123.6

430

522

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

123.4

3610

11908

SPAT1097

SPAT

Recording of ECG

2.0

122.6

1755

4670

R07.3

ICD-10 Finland

Other chest pain

2.1

122.5

1386

3372

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.7

122.4

851

1650

GD1LA

NOMESCO Finland

22.3

122.1

150

A10BA02

ATC

metformin; oral

1.6

121.9

4316

14906

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

121.7

1252

2928

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

121.7

3232

10396

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

121.1

2884

9006

Z49.1

ICD-10 Finland

Extracorporeal dialysis

+∞

121.0

155

T89

ICPC

Diabetes insulin dependent

3.4

120.8

544

807

L08

ICPC

Shoulder symptom/complaint

1.7

120.8

3247

10475

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.6

120.6

860

1690

TK800

NOMESCO Finland

Hemodialysis

7.2

120.5

252

177

L15

ICPC

Knee symptom/complaint

1.6

120.4

3501

11523

L13

ICPC

Hip symptom/complaint

1.8

120.4

2342

6895

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

119.8

3645

12133

ZYC01

NOMESCO Finland

Remote contact by phone

2.8

119.7

771

1433

Z51.6

ICD-10 Finland

Desensitization to allergens

43.1

119.6

128

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

119.5

988

2092

207

Kela drug reimbursment

Chronic arrhythmias

1.8

119.1

2094

5972

IGY02

NOMESCO Finland

Psychiatric monitoring contact

4.2

119.0

412

498

M01AE02

ATC

naproxen; oral, rectal

1.4

117.9

9361

37975

SFA30

NOMESCO Finland

Three-surface restoration

1.5

117.7

6641

25281

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

117.6

2305

6798

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

117.3

2031

5761

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

117.3

1174

2712

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

5.1

117.2

329

327

EBA00

NOMESCO Finland

Extraction of tooth

1.5

117.1

5995

22385

B01AB10

ATC

tinzaparin; parenteral

2.1

117.1

1299

3134

WX402

NOMESCO Finland

General anaesthesia

1.7

117.1

3116

10019

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

116.9

818

1591

G44.2

ICD-10 Finland

Tension-type headache

2.0

116.8

1646

4352

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

116.7

1689

4509

R55

ICD-10 Finland

Syncope and collapse

2.0

116.2

1562

4060

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

3.2

115.8

570

899

R05

ICD-10 Finland

Cough

1.7

115.7

2979

9491

P06

ICPC

Sleep disturbance

1.9

115.6

1825

5020

N30.0

ICD-10 Finland

Acute cystitis

1.9

115.3

1939

5447

W90

ICPC

Uncompl labour/delivery livebirth

7.3

115.3

239

166

P29

ICPC

Psychological sympt/compl other

2.4

115.2

1024

2243

M01AB05

ATC

diclofenac; systemic, rectal

1.4

114.9

11151

46783

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

114.7

819

1610

D01

ICPC

Abdominal pain/cramps general

2.0

114.3

1578

4141

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.1

114.0

272

226

SPAT1229

SPAT

Assessment of need for aid

2.6

113.0

834

1668

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

112.6

11893

50553

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

112.2

1577

4164

N02BF01

ATC

gabapentin; oral

2.1

111.9

1250

3023

R60.0

ICD-10 Finland

Localized oedema

2.0

111.6

1600

4255

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.1

111.4

602

1008

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

111.1

16986

77124

P20

ICPC

Memory disturbance

1.9

110.8

1720

4701

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.9

110.7

668

1196

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.2

110.6

567

918

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.5

110.5

897

1881

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

110.3

6222

23618

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

110.1

1282

3152

R74

ICPC

Upper respiratory infection acute

1.5

109.5

4916

17824

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.1

109.4

393

490

J01FA10

ATC

azithromycin; systemic

1.4

109.4

9420

38581

Z75.5

ICD-10 Finland

Holiday relief care

187.6

109.3

149

S01ED51

ATC

timolol, combinations; ophthalmic

2.4

109.3

969

2119

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.2

108.9

1153

2726

L12

ICPC

Hand/finger symptom/complaint

1.7

108.6

2410

7361

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

4.7

107.4

327

352

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.7

107.3

2453

7554

Angiography of the heart and coronary arteries

2.6

107.2

778

1542

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

107.1

4067

14214

P03

ICPC

Feeling depressed

2.1

107.1

1338

3380

C07AA05

ATC

propranolol; systemic

1.7

107.0

2685

8483

SPAT1240

SPAT

Therapeutic discussion

2.1

106.9

1303

3260

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

106.3

1001

2249

SPAT1312

SPAT

General health counselling

1.5

106.2

4511

16149

R31

ICD-10 Finland

Unspecified haematuria

2.0

106.2

1529

4069

M01AC06

ATC

meloxicam; systemic, rectal

1.5

105.9

5159

18998

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.9

105.7

1710

4737

AS4

Physiological pacemaker insertion DDD (R)

19.5

105.7

135

Z94.0

ICD-10 Finland

Kidney transplant status

+∞

105.4

135

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

105.1

3364

11298

N17

ICPC

Vertigo/dizziness

1.9

105.0

1588

4299

A04AA01

ATC

ondansetron; systemic, rectal

2.4

104.9

885

1890

H13

ICPC

Plugged feeling ear

1.7

104.8

2758

8820

SPAT1260

SPAT

Consultation of another employee

1.7

104.7

2228

6719

A10AE05

ATC

insulin detemir; parenteral

2.8

104.7

673

1249

A11CC03

ATC

alfacalcidol; systemic

5.5

104.7

275

255

M79.1

ICD-10 Finland

Myalgia

1.8

104.5

1924

5555

N03AG01

ATC

valproic acid; systemic, rectal

2.6

104.5

772

1544

GD1AD

NOMESCO Finland

Thorax CT examination

2.6

104.3

772

1545

R21

ICPC

Throat symptom/complaint

1.6

104.2

2952

9619

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

103.9

3817

13231

K78

ICPC

Atrial fibrillation/flutter

2.3

103.9

947

2097

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.0

103.8

299

305

Z71.9

ICD-10 Finland

Counselling, unspecified

2.2

103.5

1029

2368

R33

ICD-10 Finland

Retention of urine

2.1

103.3

1218

3007

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

103.3

1971

5753

WX892

NOMESCO Finland

Monitored bed care

2.3

102.7

970

2182

J01MA14

ATC

moxifloxacin; systemic

2.1

102.7

1190

2918

J01EA01

ATC

trimethoprim; systemic

1.6

102.7

3113

10313

R03BB04

ATC

tiotropium bromide; inhalant

2.0

102.5

1399

3651

X58

ICD-10 Finland

Exposure to other specified factors

1.7

102.4

2319

7117

L01

ICPC

Neck symptom/complaint

1.8

102.2

2067

6140

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

101.7

2982

9795

N05CF02

ATC

zolpidem; oral

1.7

101.7

2245

6840

B01AF02

ATC

apixaban; oral

1.9

101.6

1652

4582

A03

ICPC

Fever

1.7

101.4

2531

7975

D07AC01

ATC

betamethasone; topical

1.4

101.1

5526

20778

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

12.5

101.0

153

J01FA06

ATC

roxithromycin; oral

1.4

101.0

5907

22497

SPAT1325

SPAT

Vaccination

1.5

100.7

4635

16844

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.5

100.6

5254

19579

WX872

NOMESCO Finland

Intensive care

2.8

99.7

626

1146

O80.8

ICD-10 Finland

Other single spontaneous delivery

6.7

99.4

219

165

S29

ICPC

Skin symptom/complaint other

1.6

99.3

2776

9007

N02BF02

ATC

pregabalin; oral

2.5

99.2

771

1582

J01CA08

ATC

pivmecillinam; oral

1.5

98.7

4405

15899

M01AX05

ATC

glucosamine; oral

1.7

98.4

2271

7001

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.3

98.4

478

747

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

98.3

1250

3176

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

2.6

98.3

700

1373

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

97.9

1765

5058

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

97.8

1588

4400

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

97.6

5998

23020

Z01.7

ICD-10 Finland

Laboratory examination

1.7

97.2

2291

7102

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

97.2

1503

4096

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.3

96.2

925

2097

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

78.6

96.1

140

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.2

95.9

334

406

SPAT1043

SPAT

Audiometry

2.0

95.8

1204

3045

UDC00

NOMESCO Finland

Ear microscopy

2.3

95.7

927

2108

I25.2

ICD-10 Finland

Old myocardial infarction

2.2

95.5

998

2345

H02

ICPC

Hearing complaint

1.8

95.3

1863

5471

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.0

95.2

530

904

H91.1

ICD-10 Finland

Presbycusis

2.3

95.0

851

1868

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.0

94.9

272

276

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

94.8

1571

4380

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

94.8

2232

6915

114

Kela drug reimbursment

Glaucoma

2.1

94.7

1117

2757

D11

ICPC

Diarrhoea

1.9

94.6

1556

4328

G04BD12

ATC

mirabegron; oral

1.9

94.6

1381

3689

JN4BD

NOMESCO Finland

Extensive body CT

2.0

94.5

1229

3148

S97

ICPC

Chronic ulcer skin

2.5

94.5

735

1508

P01

ICPC

Feeling anxious/nervous/tense

1.8

94.5

1691

4833

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

94.5

616

1152

Y0399

ICD-8 Finland

Investigation of circulatory system

+∞

94.4

121

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

94.4

1669

4751

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

94.4

1276

3316

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

94.4

1123

2781

R52.9

ICD-10 Finland

Pain, unspecified

2.0

94.4

1315

3455

I50.0

ICD-10 Finland

Congestive heart failure

2.1

94.0

1089

2668

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.1

93.8

504

841

M04AA01

ATC

allopurinol; systemic

1.7

93.7

1960

5872

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

93.5

1077

2633

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.7

93.4

382

528

U02

ICPC

Urinary frequency/urgency

1.8

93.0

1590

4477

Z51.0

ICD-10 Finland

Radiotherapy session

+∞

92.9

119

A10AC01

ATC

insulin (human); parenteral

2.1

92.8

1031

2484

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.6

92.5

681

1359

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

92.5

1285

3372

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

4.5

92.4

294

330

C03DA01

ATC

spironolactone; oral

1.8

92.2

1615

4583

L04AD02

ATC

tacrolimus; systemic

109.4

92.0

130

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

92.0

2932

9807

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

91.6

3389

11729

R4190

NOMESCO Finland

Nutritional therapy

3.2

91.5

455

722

8221

FHL

Sterilization of the laparotomy pathway

8.6

91.5

169

L29

ICPC

Musculoskeletal sympt/complt other

2.1

91.2

1053

2576

A02BA02

ATC

ranitidine; systemic

1.6

91.2

2617

8532

R03DC03

ATC

montelukast; oral

1.7

90.8

2091

6435

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.0

90.6

1240

3236

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

24.8

90.5

108

N06AA09

ATC

amitriptyline; systemic

2.1

90.4

1032

2513

O81.4

ICD-10 Finland

Vacuum extractor delivery

5.2

90.3

247

239

J05AB01

ATC

aciclovir; systemic

1.6

90.2

2861

9554

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

3.3

90.2

421

640

SPAT1234

SPAT

Support of social functional capacity

2.7

90.2

619

1190

P76

ICPC

Depressive disorder

2.3

90.2

820

1812

N06AB03

ATC

fluoxetine; oral

1.9

90.1

1490

4149

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

204.7

90.0

122

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.1

89.9

323

403

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.4

89.8

791

1723

Z31.6

ICD-10 Finland

General counselling and advice on procreation

20.4

89.7

113

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

89.6

1170

3000

N05BA01

ATC

diazepam; systemic, rectal

1.8

89.5

1745

5117

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

89.5

4334

15857

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.2

89.2

931

2185

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

88.5

812

1802

R01AD08

ATC

fluticasone; nasal

1.5

88.1

4025

14550

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

87.4

2993

10168

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.6

87.4

603

1163

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.9

87.1

1394

3839

H29

ICPC

Ear symptom/complaint other

1.8

86.9

1589

4568

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

86.8

1088

2747

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.0

86.6

1098

2784

A11

ICPC

Chest pain NOS

2.1

86.5

1043

2594

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

36.8

86.5

TMA00

NOMESCO Finland

Episiotomy

34.6

86.4

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.1

86.0

1004

2466

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.7

85.8

261

281

XA800

NOMESCO Finland

Neuropsychological investigation

2.8

85.7

530

962

G04CA01

ATC

alfuzosin; oral

1.7

85.4

2089

6528

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.8

85.1

1448

4067

Y0499

ICD-8 Finland

Investigation of respiratory system

+∞

85.1

109

C10AX09

ATC

ezetimibe; oral

1.6

84.9

2273

7272

R5599

NOMESCO Finland

Other rehabilitation service

4.0

84.9

307

385

R52.2

ICD-10 Finland

Other chronic pain

3.3

84.9

411

641

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.3

84.8

397

605

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

88.0

84.8

122

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

84.7

4017

14615

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

5.7

84.4

213

189

S01EE01

ATC

latanoprost; ophthalmic

2.4

84.3

737

1599

Z49.0

ICD-10 Finland

Preparatory care for dialysis

+∞

84.3

108

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

28.8

84.2

SDA03

NOMESCO Finland

Periodontal treatment

1.4

83.6

6172

24314

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

83.6

1947

6003

A99

ICPC

Disease/condition unspecnature/site

1.9

83.3

1370

3805

O82.0

ICD-10 Finland

Delivery by elective caesarean section

5.6

82.9

213

193

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

82.6

1004

2505

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

82.5

697

1488

M54.2

ICD-10 Finland

Cervicalgia

2.1

82.5

997

2482

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

187.7

82.3

112

H02AB04

ATC

methylprednisolone; systemic

1.7

82.1

1842

5620

Y4300

ICD-8 Finland

Preventive sterilization, Legal sterilization, medical reasons (illness or physical injury)

+∞

81.9

105

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.3

81.8

780

1760

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

81.8

1157

3053

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.3

81.7

741

1635

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.5

81.6

629

1284

N06AX12

ATC

bupropion; oral

2.1

81.5

932

2270

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

274.5

81.4

109

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

81.3

998

2499

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

81.3

662

1389

H03AA01

ATC

levothyroxine sodium; systemic

1.6

81.2

2662

8941

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

81.2

780

1766

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.4

81.1

668

1409

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.1

81.0

960

2371

WW500

NOMESCO Finland

Blood transfusion

3.1

80.8

430

713

SPAT1053

SPAT

Memory test

1.8

80.8

1586

4655

M01AH01

ATC

celecoxib; oral

1.6

80.8

2224

7162

SPAT1255

SPAT

Intravenous administration of medicine

2.3

80.7

778

1764

O68.0

ICD-10 Finland

Labour and delivery complicated by fetal heart rate anomaly

5.8

80.7

200

174

N05AX08

ATC

risperidone; systemic

1.9

80.6

1270

3477

N06AX26

ATC

vortioxetine; oral

2.1

80.3

970

2413

I44.1

ICD-10 Finland

Atrioventricular block, second degree

4.8

80.3

239

252

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

80.3

770

1742

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

80.2

650

1360

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

80.2

704

1530

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

20.4

80.2

101

U04

ICPC

Incontinence urine

2.5

80.1

596

1195

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

79.8

839

1974

O48

ICD-10 Finland

Prolonged pregnancy

7.2

79.6

167

118

D07AC13

ATC

mometasone; topical

1.4

79.6

4223

15672

137

Kela drug reimbursment

Uraemia requiring dialysis

18.1

79.5

104

R96

ICPC

Asthma

2.0

79.4

1106

2901

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

3.3

79.4

370

562

R29

ICPC

Respiratory symptom/complaint other

2.2

79.4

846

2002

WX321

NOMESCO Finland

Acute spinal anesthesia for delivery

7.9

79.4

155

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

79.3

874

2097

B05DA

ATC

Isotonic solutions

32.0

79.0

MAA00

NOMESCO Finland

Amniocentesis

26.0

78.9

R03BA05

ATC

fluticasone; inhalant

1.6

78.9

2475

8225

H02AB02

ATC

dexamethasone; systemic

1.9

78.8

1284

3554

RF410, ,

NOMESCO Finland

11.3

78.7

125

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

78.6

595

1204

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

78.5

3937

14452

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

78.3

652

1382

SPAT1211

SPAT

Application of soft bandage

2.0

78.2

1079

2821

A10AB04

ATC

insulin lispro; parenteral

3.4

78.1

357

535

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

2.6

78.1

545

1057

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

78.1

866

2083

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

+∞

78.0

100

K30

ICD-10 Finland

Functional dyspepsia

1.8

78.0

1338

3765

C07AB02

ATC

metoprolol; systemic

1.5

77.9

2831

9725

A12AA04

ATC

calcium carbonate; oral

6.6

77.7

174

134

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.8

77.5

484

883

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.7

77.5

309

419

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.7

77.4

523

997

Y0609

ICD-8 Finland

Examination of the urinary and genital organs, Genital organs

+∞

77.3

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

77.2

471

848

N01

ICPC

Headache

1.8

77.2

1483

4322

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

77.2

889

2171

H01

ICPC

Ear pain/earache

1.8

77.1

1505

4407

R01AD12

ATC

fluticasone furoate; nasal

1.4

77.1

4435

16691

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.0

77.1

1042

2704

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.9

77.0

450

790

N03AE01

ATC

clonazepam; systemic

2.4

77.0

654

1400

TFP20

NOMESCO Finland

Cardiodefibrillation

2.1

76.9

901

2215

I20.09

ICD-10 Finland

Unstable angina

2.3

76.9

726

1631

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

76.7

1480

4319

M02AA07

ATC

piroxicam; topical

1.4

76.6

5138

19858

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

76.4

960

2424

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

76.4

2807

9664

Z50.0

ICD-10 Finland

Cardiac rehabilitation

503.9

76.1

100

A10BH01

ATC

sitagliptin; oral

1.9

75.9

1144

3084

N05AX12

ATC

aripiprazole; systemic

2.7

75.7

519

997

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.8

75.7

463

835

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.8

75.7

1333

3782

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.1

75.6

871

2127

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.8

75.3

298

402

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

75.1

1297

3657

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

106.9

75.0

106

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

75.0

1305

3688

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

19.9

75.0

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

8.8

74.9

137

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

74.9

1058

2788

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

74.6

1365

3919

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

12.4

74.5

113

B01AF01

ATC

rivaroxaban; oral

1.7

74.3

1526

4534

W19

ICD-10 Finland

Unspecified fall

1.8

74.3

1421

4135

S01BC05

ATC

ketorolac; ophthalmic

2.7

74.2

497

943

Z39.1

ICD-10 Finland

Care and examination of lactating mother

37.1

73.9

N04BC05

ATC

pramipexole; oral

2.1

73.8

851

2078

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

73.5

1266

3566

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

+∞

73.3

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

73.1

4232

15922

N05BA12

ATC

alprazolam; oral

1.9

73.1

1194

3306

M01AX17

ATC

nimesulide; oral

1.5

72.7

3157

11247

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

72.7

5434

21349

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.0

72.3

402

685

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.0

71.8

1008

2650

A10BK03

ATC

empagliflozin; oral

1.8

71.7

1320

3795

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

71.5

659

1464

P74

ICPC

Anxiety disorder/anxiety state

2.5

71.5

532

1067

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

71.4

776

1850

E000001, ,

ATC

1.5

71.4

2742

9519

G04CB01

ATC

finasteride; oral

1.7

71.3

1753

5474

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.7

71.2

481

917

Z72.1

ICD-10 Finland

Alcohol use

6.7

71.0

157

119

V220A

ICD-9 Finland

Normal pregnancy, Supervision of normal first pregnancy

+∞

71.0

HMAK, ,

NOMESCO Finland

1.8

70.6

1337

3877

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.3

70.3

643

1424

M05BX04

ATC

denosumab; parenteral

2.4

70.2

573

1203

MAE00

NOMESCO Finland

Outlet vacuum delivery

5.0

69.9

198

199

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.2

69.8

747

1770

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.1

69.5

769

1847

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.9

69.4

400

697

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

69.3

888

2258

R06.5

ICD-10 Finland

Mouth breathing

1.8

69.1

1280

3687

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

69.0

1464

4388

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

69.0

1324

3854

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

68.8

851

2135

L02

ICPC

Back symptom/complaint

1.8

68.8

1324

3857

O02.1

ICD-10 Finland

Missed abortion

4.1

68.6

244

302

S01EC04

ATC

brinzolamide; ophthalmic

2.9

68.6

404

713

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030467) Casts [#/volume] in Urine by Automated count

5446

15845

1.97

322.16

3.6

2.5

0.42

0.45

e6/l

0.38

4089

10419

(3015377) Calcium [Moles/volume] in Serum or Plasma

6274

19190

1.90

321.05

3.6

2.7

2.35

2.36

mmol/l

3.71

5731

17448

(3009261) Glucose [Presence] in Urine by Test strip

9820

34641

1.77

318.56

4.0

2.8

0.16

0.39

estimate

0.36

1985

5506

(3018418) pH of Serum or Plasma

5635

16658

1.94

317.94

4.8

2.8

7.40

5.89

4107

10658

(3026782) Osmolality of Urine

3851

9863

2.17

317.39

3.1

2.2

544.21

573.77

mosm/kgh2o

10.78

3387

8448

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

326

50.32

311.11

1.6

1.1

61.76

34.92

ug/l

3.86

281

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

16908

70613

1.93

307.96

16.9

9.2

83.11

84.24

ml/min/173m2

8.51

15689

63002

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2989

6641

2.46

307.65

2.9

1.8

23.18

24.59

5.00

2813

6105

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

14215

49670

2.27

307.65

8.9

5.4

80.13

76.95

u/l

8.92

13598

46602

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8702

28454

1.90

307.65

3.2

2.3

141.58

131.12

ug/l

1.93

8143

26712

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4674

12535

2.11

307.65

2.6

1.9

—

(3032080) INR in Blood by Coagulation assay

9019

25199

2.37

307.65

16.2

10.1

1.28

1.23

inr

11.84

7671

20040

(3037467) Urinalysis macro (dipstick) panel - Urine

12410

42871

2.06

307.65

4.6

3.1

3.01

2.84

0.09

107

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7446

22174

2.05

307.65

4.0

2.6

67.79

64.32

ng/l

0.09

5324

13796

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6695

20812

1.89

307.65

3.6

2.5

37.63

35.73

u/l

0.28

6348

19540

(46235355) HIV 1 and 2 tests - Meaningful Use set

3963

9712

2.28

307.65

2.1

1.6

—

(42870588) Differential panel, method unspecified - Blood

6649

18927

2.10

307.65

6.9

5.3

—

5.98

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5765

14234

2.41

307.65

3.4

2.3

1603.18

1240.64

ng/l

5.49

4895

11912

(3006504) Eosinophils/Leukocytes in Blood

9090

27645

2.12

307.65

7.1

5.2

2.86

2.91

0.96

8597

25807

(3002030) Lymphocytes/Leukocytes in Blood

9315

29233

2.05

307.65

7.1

5.1

27.60

28.70

15.24

8903

27574

(3019550) Sodium [Moles/volume] in Serum or Plasma

17973

74656

2.23

307.65

20.8

10.7

139.63

139.88

mmol/l

32.52

17637

72615

(3023368) Bacteria identified in Blood by Culture

5717

14742

2.29

307.65

4.7

3.3

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

13433

48224

2.05

307.65

4.5

3.2

11.71

10.25

mm/h

21.93

12613

44914

(3023103) Potassium [Moles/volume] in Serum or Plasma

17999

74996

2.22

307.65

21.0

10.8

3.99

3.98

mmol/l

5.47

17626

72759

(3013826) Glucose [Moles/volume] in Serum or Plasma

11291

35008

2.30

307.65

5.8

3.5

6.74

6.71

mmol/l

0.73

10759

32950

(3021960) Folate [Moles/volume] in Serum or Plasma

5260

14966

2.01

307.65

1.7

1.5

19.47

19.39

nmol/l

0.15

4561

12632

(3001604) Monocytes [#/volume] in Blood

9839

30594

2.13

307.65

6.9

5.0

0.60

0.59

e9/l

2.29

8574

25400

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5149

12940

2.31

307.65

2.4

1.9

2.82

2.74

mg/l

1.16

4444

10968

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3463

7751

2.48

307.65

2.0

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

16200

65303

1.98

307.65

5.1

3.9

1.90

1.93

mu/l

0.86

15056

60183

(3019069) Monocytes/Leukocytes in Blood

9108

27781

2.12

307.65

7.2

5.3

9.00

8.90

2.49

8619

25929

(3044640) Blood type and Crossmatch panel - Blood

6070

17114

2.08

307.65

2.7

1.9

—

(3019198) Lymphocytes [#/volume] in Blood

10056

31785

2.10

307.65

7.0

5.0

1.91

1.97

e9/l

1.96

8962

27230

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3187

6695

2.63

307.65

1.7

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

8507

25336

2.13

307.65

5.8

3.5

35.68

36.40

g/l

20.93

8020

23478

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3220

7321

2.42

307.65

2.8

1.7

2.29

2.35

g/l

8.05

3010

6657

(3022096) Basophils/Leukocytes in Blood

9072

27716

2.11

307.65

7.2

5.3

0.67

0.68

0.84

8585

25821

(3006315) Basophils [#/volume] in Blood

9858

30654

2.13

307.65

6.9

5.0

0.04

e9/l

0.73

8591

25415

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

589

256

11.84

307.65

1.6

1.3

975.90

1081.42

mu/l

0.84

512

224

(3013512) EKG study

6339

17918

2.10

307.65

3.7

2.7

0.70

0.77

0.24

(3002582) Erythrocytes [#/volume] in Urine

6351

18457

2.03

307.65

3.7

2.5

108.69

95.35

e6/l

0.24

4943

13003

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8118

26009

1.91

307.65

2.2

1.8

94.41

95.15

pmol/l

0.66

4518

13519

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8529

24697

2.21

307.65

7.6

4.6

1.21

mmol/l

1.88

7922

22731

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3452

7815

2.45

307.65

4.0

2.4

0.82

0.83

mmol/l

7.45

3265

7308

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6239

17108

2.17

307.65

2.9

2.1

71.40

63.19

u/l

0.28

5841

15805

(3013650) Neutrophils [#/volume] in Blood by Automated count

10939

35177

2.13

307.65

10.5

7.0

4.15

4.17

e9/l

0.47

9598

29371

(3022948) Iron [Moles/volume] in Serum or Plasma

3445

7929

2.40

307.65

2.8

1.8

13.12

14.27

umol/l

12.29

3235

7309

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

10085

29474

2.34

307.65

7.1

4.4

12.03

12.55

umol/l

2.37

9668

27844

(3026008) Bacteria identified in Urine by Culture

5228

14257

2.11

307.65

3.3

2.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2815

6003

2.56

307.65

7.3

3.2

1.05

1.01

mmol/l

6.85

2631

5521

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6003

16470

2.15

307.65

2.4

1.9

253.94

250.18

u/l

0.05

5705

15521

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

13561

51570

1.86

307.65

4.1

3.3

14.80

14.70

pmol/l

4.35

12470

46903

(3013115) Eosinophils [#/volume] in Blood

10157

31741

2.14

307.65

7.2

5.2

0.20

e9/l

0.57

8984

26988

(3035350) Ketones [Presence] in Urine by Test strip

9787

34330

1.79

307.65

3.9

2.8

5.35

3.92

estimate

0.28

2143

5837

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

17801

72974

2.27

307.65

17.9

8.9

25.04

26.47

mg/l

5.59

14978

55108

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9483

27000

2.36

307.65

8.3

4.5

1.21

mmol/l

9.46

8277

22540

(3019832) Treponema pallidum Ab [Presence] in Serum

1951

3477

3.00

307.65

2.0

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8165

26827

1.85

307.65

2.5

2.0

75.34

75.62

nmol/l

0.36

7456

24464

(3021601) Nitrite [Presence] in Urine by Test strip

9684

33829

1.79

307.65

3.9

2.8

0.00

estimate

0.44

2109

5783

(3031040) Bacteria [#/volume] in Urine by Automated count

11767

38773

2.15

307.65

4.7

3.2

1406.12

1240.07

e6/l

0.13

164

887

(3000850) Epithelial cells [#/volume] in Urine

4449

11932

2.10

307.65

2.9

2.1

4.63

5.15

e6/l

1.80

4074

10663

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8646

25758

2.14

307.65

3.0

2.2

—

estimate

—

(3021589) Normoblasts [#/volume] in Blood

8468

27666

1.88

307.65

12.2

8.0

0.00

e9/l

0.26

6996

21183

(3018095) Leukocytes [#/volume] in Urine

7146

21542

1.99

307.65

4.3

2.9

100.27

85.13

e6/l

0.51

5190

14004

(3018010) Neutrophils/Leukocytes in Blood

9170

28304

2.09

307.65

6.9

5.0

57.32

56.57

6.75

8810

26978

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3146

7484

2.30

307.19

2.3

1.6

29.82

29.65

0.74

3059

7288

(3020779) Urea [Moles/volume] in Serum or Plasma

2041

3935

2.77

303.39

8.9

3.3

10.06

9.37

mmol/l

3.18

1961

3712

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4315

11751

2.05

302.94

1.9

1.4

1.23

1.18

mg/l

0.38

3271

9033

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2423

5124

2.55

302.76

4.5

3.8

246.32

236.59

u/l

1.38

2305

4855

(36304419) Bacteria [Presence] in Urine

5210

15368

1.92

291.75

3.5

2.5

102.00

0.74

estimate

0.48

(40758558) Short blood count panel - Blood

5749

17610

1.87

286.89

7.0

4.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

300

47.70

284.24

1.5

1.1

0.94

1.06

ratio

—

190

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

300

47.70

284.24

1.5

1.1

1.24

0.87

ratio

—

190

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

300

47.70

284.24

1.5

1.1

1.19

1.11

ratio

—

190

(3042936) Bacteria identified in Isolate by Culture

2962

7098

2.27

282.70

2.2

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2592

5882

2.38

278.82

1.9

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2636

6030

2.36

278.69

1.8

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

291

49.33

276.98

1.5

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

3197

7997

2.18

275.38

1.8

1.6

1174.73

1187.20

nmol/l

0.28

2438

6045

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3843

10353

2.05

274.55

4.1

2.8

384.07

682.85

ng/l

4.71

2981

7999

(3020564) Creatinine [Moles/volume] in Serum or Plasma

18718

82285

2.06

261.62

22.6

11.9

81.94

77.71

umol/l

43.22

18496

81073

(3015736) pH of Urine

7924

27592

1.70

249.98

3.5

2.6

6.21

6.11

12.44

4593

15137

(3044889) 12 lead EKG panel

12633

49755

1.66

249.69

4.2

3.1

3741.74

5576.63

0.13

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2458

5733

2.30

247.21

2.0

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2218

4967

2.38

243.62

4.3

2.3

5.84

5.82

kpa

0.52

2150

4853

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

16682

71097

1.78

243.02

5.0

4.1

6.00

5.85

mmol/l

37.13

15388

65842

(3043238) Trisomy 21 risk [Likelihood] in Fetus

244

61.92

238.73

1.6

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1761

3555

2.62

238.20

2.5

1.8

7.76

8.30

ug/l

0.34

1563

3152

(3012544) pH of Venous blood

2243

5102

2.35

237.92

4.3

2.4

7.38

2.70

1364

2418

(3002032) Base excess in Venous blood by calculation

2164

4870

2.37

234.76

4.3

2.3

1.75

1.76

mmol/l

0.05

1836

4283

(40768797) Stomach Pathology biopsy report

2628

6476

2.18

231.73

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

18524

81933

1.94

231.55

12.8

7.8

28.69

28.29

u/l

1.00

18070

79339

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1901

4063

2.48

229.51

2.2

2.3

378.12

385.11

nmol/l

0.67

1767

3803

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1985

4334

2.43

229.35

2.4

1.9

0.21

0.22

g/l

2.05

1843

4000

(3007853) Bacteria identified in Skin by Aerobe culture

2413

5772

2.24

228.03

1.8

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

6626

22414

1.70

226.89

3.7

2.9

8.10

8.58

mmol/l

10.94

5719

19179

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1479

2798

2.77

225.05

3.9

2.5

5.15

5.16

kpa

0.12

1422

2664

(3027801) Oxygen [Partial pressure] in Arterial blood

2454

5960

2.20

223.52

8.9

6.9

12.12

12.51

kpa

2.49

2365

5691

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2453

5962

2.20

223.00

9.0

6.9

5.11

5.10

kpa

0.14

2364

5705

(3050129) First trimester maternal screen panel - Serum or Plasma

386

204

9.65

222.15

1.4

1.6

—

(3019977) pH of Arterial blood

2447

5990

2.18

218.43

9.0

6.9

7.41

7.42

1.55

1403

2918

(3003396) Base excess in Arterial blood by calculation

2438

5986

2.18

215.91

8.9

6.8

0.98

0.87

mmol/l

0.57

1996

4916

(3007164) IgA [Mass/volume] in Serum or Plasma

3919

11471

1.87

215.73

1.6

1.3

2.48

2.43

g/l

0.69

2490

7703

(3016502) Oxygen saturation in Arterial blood

2211

5214

2.26

215.24

9.3

7.4

95.56

95.50

0.13

2138

5005

(3009343) pH of Capillary blood

1439

2761

2.73

213.17

4.0

2.5

7.41

7.42

2.32

1220

2181

(3027945) Reticulocytes/Erythrocytes in Blood

2343

5708

2.19

211.15

3.0

2.2

1.80

1.67

6.13

2109

5052

(3007461) Platelets [#/volume] in Blood

19170

86448

2.00

208.78

26.6

13.7

245.94

249.46

e9/l

10.94

18830

83693

(3010813) Leukocytes [#/volume] in Blood

19186

86579

2.00

207.58

26.6

13.7

6.81

6.56

e9/l

30.49

18797

83395

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

19179

86547

1.99

207.20

27.2

13.9

41.03

43.05

7.70

18977

85231

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3173

8749

1.96

207.14

3.3

2.5

1.91

2.14

e6/l

0.57

1605

3258

(3035941) MCH [Entitic mass]

19177

86544

1.99

206.87

26.5

13.6

30.36

30.31

2.66

18983

85293

(3000963) Hemoglobin [Mass/volume] in Blood

19185

86604

1.99

206.47

26.8

13.8

136.99

140.53

g/l

170.83

18993

85404

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1495

2978

2.63

206.44

1.7

1.4

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

19175

86547

1.99

206.32

26.5

13.6

90.90

90.51

25.57

18982

85297

(3026361) Erythrocytes [#/volume] in Blood

19178

86566

1.99

206.30

26.6

13.7

4.55

4.66

e12/l

143.36

18793

83391

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1796

3939

2.41

204.60

1.6

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4327

13270

1.80

204.30

1.3

1.2

2.07

1.94

u/ml

0.17

1191

3880

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1898

4311

2.33

200.35

4.4

4.3

16.50

26.61

ug/l

0.83

1562

3431

(3033658) Prothrombin time (PT) actual/Normal

4922

15770

1.73

199.85

4.7

2.9

87.86

89.59

4.83

4819

15399

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1270

2355

2.81

199.59

3.8

2.5

1.56

1.86

mmol/l

1.78

954

1699

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

16386

70775

1.67

199.06

6.4

4.9

39.61

38.31

mmol/mol

51.71

15465

66569

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

12821

52166

1.57

198.82

3.6

2.5

52.52

43.33

u/l

19.49

12190

49428

(3023520) Reticulocytes [#/volume] in Blood

1806

4027

2.36

198.38

2.9

2.2

70.04

68.78

e9/l

0.63

1341

2777

(3024354) Oxygen [Partial pressure] in Venous blood

1852

4212

2.32

194.70

3.6

2.1

4.61

4.51

kpa

1.19

1793

4103

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2345

5904

2.11

194.03

3.1

2.1

8.31

8.87

umol/l

0.53

2072

5187

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3405

9861

1.87

191.16

3.2

2.4

0.93

1.16

e6/l

2.74

1841

4359

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1282

2452

2.73

190.46

1.7

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

6061

20824

1.64

188.21

4.5

3.6

10.03

5.00

mg/mmol

10.99

4031

12848

(3014111) Lactate [Moles/volume] in Serum or Plasma

1973

4684

2.23

187.87

8.8

6.9

1.39

mmol/l

0.03

1926

4591

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

14954

63473

1.59

187.64

21.5

11.2

13.61

13.41

65.00

14780

62117

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2045

4933

2.19

187.53

9.9

7.7

123.41

125.60

g/l

3.89

2005

4800

(3045414) Leukocytes [Presence] in Urine

1754

3958

2.33

187.32

2.2

1.7

0.01

0.05

estimate

3.42

394

746

(3017181) Myelocytes/Leukocytes in Blood

1811

4164

2.29

185.45

4.8

3.6

0.91

0.90

0.05

595

1105

(3005719) IgG [Mass/volume] in Serum or Plasma

1643

3622

2.38

184.44

3.0

2.3

10.60

10.95

g/l

1.96

1528

3326

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7415

26910

1.58

183.27

3.9

2.7

0.03

0.47

estimate

1.48

1758

4844

(3025159) Blasts/Leukocytes in Blood

1756

4004

2.31

183.11

5.0

3.7

0.25

0.19

0.15

475

932

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3592

10784

1.81

178.95

3.1

2.6

2.45

2.44

mmol/l

2.28

3210

9507

(3012516) Albumin [Mass/volume] in Urine

5938

20564

1.62

176.40

3.7

3.0

54.64

34.97

mg/l

7.67

4030

13028

(3019225) pH of Specimen

1709

3930

2.28

174.54

4.7

2.7

7.35

7.32

4.75

1282

2613

(3002179) Metamyelocytes/Leukocytes in Blood

1722

3980

2.27

173.84

4.6

3.6

0.72

0.64

0.61

556

1010

(3047352) Trisomy 18 risk [Likelihood] in Fetus

241

136.14

173.09

1.5

1.0

—

(3000991) Gas panel - Venous blood

1901

4604

2.18

171.98

10.5

7.3

—

(3021440) Promyelocytes/Leukocytes in Blood

1724

4010

2.26

171.46

4.9

3.7

0.10

0.11

0.21

509

957

(3029937) Albumin [Presence] in Urine by Test strip

5357

18256

1.63

168.15

4.1

3.0

0.01

0.00

estimate

0.63

1923

5157

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1430

3097

2.41

166.13

4.8

2.5

95.51

77.61

ng/l

8.65

1275

2691

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

921

1577

3.02

164.99

2.0

1.7

1.84

2.72

ug/l

0.90

814

1414

(3037522) Nuclear Ab [Titer] in Serum

2611

7278

1.91

162.10

1.4

1.3

440.15

564.45

titre

2.48

537

1278

(3020630) Protein [Mass/volume] in Serum or Plasma

1643

3835

2.24

161.75

2.9

2.1

66.49

67.08

g/l

2.01

1517

3503

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

16336

71724

1.59

161.56

4.3

3.6

1.34

1.31

mmol/l

3.75

15168

67047

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1949

4897

2.10

160.51

2.8

2.1

63.92

43.55

u/l

0.39

1666

4160

(3017732) Neutrophils [#/volume] in Blood

2407

6578

1.94

157.97

3.5

2.6

4.94

4.66

e9/l

0.39

2121

5773

(3022313) Gas panel - Capillary blood

1025

1918

2.77

157.81

4.2

2.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1652

3939

2.20

154.47

2.5

2.0

0.39

0.43

e6/l

0.29

1577

3645

(3037121) Protein [Mass/volume] in Urine

747

1174

3.27

152.76

3.5

2.7

468.03

670.72

mg/l

0.40

368

525

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3810

12156

1.70

151.28

1.7

29816802.45

36615323.35

pmol/l

0.29

3213

10239

(3014051) Protein [Presence] in Urine by Test strip

5259

18243

1.59

150.69

3.0

2.1

0.06

113

391

(3011397) Hemoglobin [Presence] in Urine by Test strip

4420

14705

1.64

149.72

3.8

2.9

0.20

0.15

0.17

163

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

17375

77847

1.61

149.69

5.7

4.8

2.67

2.83

mmol/l

93.88

16277

73351

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

979

1840

2.75

149.42

1.9

1.5

1.52

1.56

g/l

0.58

862

1573

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

17166

76782

1.59

146.91

5.1

4.3

4.54

4.74

mmol/l

112.45

16163

72727

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1337

2984

2.33

145.08

4.5

2.2

24.05

24.34

mmol/l

2.35

1323

2949

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

17058

76269

1.58

144.51

5.0

4.2

1.38

1.42

mmol/l

30.59

15953

71793

(3003694) ABO and Rh group [Type] in Blood

5309

18619

1.57

144.13

1.4

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

5027

17421

1.58

143.43

3.0

2.2

356.05

351.00

umol/l

2.66

4479

15650

(3028707) Methadone [Presence] in Urine by Screen method

534

693

3.94

141.64

3.4

2.2

—

(3048689) Calprotectin [Mass/mass] in Stool

2507

7204

1.84

140.62

2.7

135.68

133.83

ug/g

0.09

2045

5922

(3004119) Hemoglobin [Mass/volume] in Venous blood

1341

3056

2.28

138.77

3.5

2.1

129.54

135.67

g/l

14.10

1306

2988

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1453

3447

2.20

136.97

9.7

6.8

24.84

24.72

mmol/l

0.59

1442

3417

(3028026) IgM [Mass/volume] in Serum or Plasma

1278

2883

2.30

135.20

2.0

1.8

1.30

1.33

g/l

0.13

1194

2672

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

642

989

3.33

135.10

1.3

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1495

3614

2.16

134.62

3.2

2.1

221.51

188.55

ng/l

1.54

1361

3269

(3000494) Fungus identified in Specimen by Culture

2415

6976

1.83

132.76

1.6

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

769

1350

2.93

131.89

2.1

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

4392

14998

1.59

131.52

4.9

3.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

815

1492

2.81

130.10

4.3

2.6

24.66

24.87

mmol/l

1.20

767

1371

(3041096) Erythrocytes [Presence] in Urine by Automated

5343

19171

1.53

128.48

3.4

2.3

0.03

0.23

estimate

1.29

1666

4561

(3015235) Bicarbonate [Moles/volume] in Capillary blood

774

1387

2.87

128.18

2.9

2.3

24.75

24.90

mmol/l

0.39

765

1365

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3213

10204

1.68

127.43

1.3

1.2

29.48

41.72

iu/ml

1.90

962

3169

(3045424) Erythrocytes [Presence] in Urine

932

1857

2.59

127.34

2.2

1.7

0.83

0.06

estimate

0.46

303

528

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

933

1898

2.53

122.35

5.6

3.6

1.66

1.69

0.26

886

1774

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2966

9318

1.69

121.92

1.3

1.2

9.77

11.19

u/ml

0.51

1160

3895

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

709

1243

2.93

121.80

1.9

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1308

3128

2.17

120.52

2.5

2.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

251

178

7.15

119.21

1.8

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1272

3026

2.18

118.65

11.5

9.5

24.32

24.30

mmol/l

0.08

1243

2952

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

516

753

3.50

117.24

7.0

1.7

711.10

839.78

iu/ml

0.13

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

164

103.66

115.48

1.3

1.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1979

5612

1.85

114.28

3.7

2.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1400

3523

2.06

113.38

11.5

9.1

93.87

93.67

0.54

1391

3510

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

270

224

6.11

113.34

2.4

2.1

30.09

41.63

iu/ml

0.31

(4024509) Urine culture

821

1626

2.59

113.32

2.0

1.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1360

3385

2.08

113.29

11.6

9.3

0.64

0.05

1347

3362

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

263

212

6.29

113.07

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

4440

15678

1.53

112.36

3.9

3.1

1.36

1.13

kg/l

0.28

2985

8936

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

428

561

3.89

112.07

3.2

1.3

1578.67

4529.95

u/ml

0.74

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1402

3558

2.05

110.99

11.3

8.9

1.35

1.33

0.21

1392

3526

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1074

2461

2.25

109.18

1.8

1.6

0.33

0.32

mg/l

0.14

558

1284

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

911

1950

2.40

107.52

2.1

1.9

39.33

39.35

u/l

0.01

811

1764

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

138

18.83

106.88

6.6

3.1

8.51

8.19

0.16

138

(40761995) Spermatozoa Progressive [#/volume] in Semen

138

18.83

106.88

3.3

1.5

45.09

42.16

0.32

138

(3005322) IgE [Units/volume] in Serum or Plasma

1287

3206

2.08

106.81

1.3

1.2

251.78

301.10

u/ml

0.55

1198

2984

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

785

1570

2.57

106.26

1.5

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

525

831

3.22

106.01

3.0

2.1

36.00

35.79

umol/l

0.03

478

745

(3007930) Methemoglobin/Hemoglobin.total in Blood

853

1790

2.45

104.88

5.9

3.8

0.87

0.91

2.84

811

1669

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

784

1580

2.55

104.54

2.4

2.0

445.14

712.57

ug/l

1.20

747

1505

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2419

7485

1.70

103.80

2.4

1.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

705

1350

2.68

103.59

3.2

2.4

0.33

0.37

iu/ml

1.24

403

684

(3022145) Colonoscopy Study observation

2138

6399

1.75

103.05

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1199

2955

2.10

102.15

12.2

8.5

16.21

16.64

4.72

1163

2832

(3029634) Reagin Ab [Titer] in Serum by VDRL

399

533

3.81

101.99

2.6

1.5

19.38

4.56

titre

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1155

2808

2.12

101.82

3.1

2.1

1.31

1.30

0.05

1146

2796

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

273

259

5.35

101.71

1.7

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

493

770

3.27

101.56

1.6

1.1

20.44

16.38

u/ml

0.40

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1295

3314

2.02

99.99

7.4

5.5

24.42

24.41

mmol/l

0.01

1245

3149

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2256

6923

1.71

99.46

2.3

1.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

943

2130

2.28

98.89

3.8

2.3

25.13

25.12

mmol/l

0.02

906

2042

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1033

2429

2.19

98.70

4.2

2.7

49.26

48.54

0.35

1013

2398

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

491

782

3.20

98.21

1.6

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

725

1456

2.55

97.28

2.8

2.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1486

4041

1.91

96.71

4.3

2.8

1.22

1.23

mmol/l

0.88

1306

3288

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

548

950

2.94

95.81

1.3

1.1

43.20

47.21

u/ml

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1126

2784

2.09

95.01

3.1

2.1

0.61

0.62

0.23

1119

2778

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2118

6485

1.71

93.80

4.8

4.1

31.25

31.00

0.43

1448

4196

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

650

1264

2.63

92.75

2.9

2.0

3.55

3.72

g/l

1.59

621

1209

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

729

1522

2.45

90.46

3.9

2.0

1.53

1.28

mg/l

11.45

671

1386

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7618

30798

1.37

89.69

5.0

4.6

3.28

2.56

ug/l

0.67

6921

28236

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

564

1039

2.77

88.83

1.8

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

513

895

2.92

88.73

1.3

1.1

263.60

227.80

u/ml

1.54

304

540

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

450

730

3.14

87.51

1.6

1.1

148.82

141.44

au/ml

0.50

128

223

(4035726) Immunohistochemistry procedure

1522

4335

1.82

85.67

1.5

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

729

1562

2.39

85.67

3.7

3.2

5786.74

6224.27

u/ml

0.03

629

1336

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

784

1738

2.31

85.59

2.4

1.9

4.19

4.20

g/l

0.03

724

1588

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

783

1736

2.31

85.46

2.4

1.9

3.72

3.93

g/l

2.01

724

1585

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

784

1740

2.31

85.37

2.4

1.9

7.35

7.38

g/l

0.13

724

1585

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

217

195

5.63

85.04

1.6

1.4

54.83

64.81

ug/l

0.98

217

195

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2834

9565

1.56

84.99

2.0

1.6

1.52

1.36

17.07

2513

8613

(3000330) Specific gravity of Urine by Test strip

899

2129

2.17

84.25

3.6

2.3

1.02

ratio

3.47

839

1855

(3034274) Bile acid [Moles/volume] in Serum --fasting

194

155

6.33

84.09

2.3

1.4

7.66

14.77

umol/l

0.89

146

102

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

572

1095

2.67

84.02

1.8

1.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1552

4477

1.80

83.80

2.9

2.0

66.57

72.54

ml/min/173m2

5.67

637

1772

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

319

419

3.86

83.35

6.3

4.9

11.66

11.33

mg/l

0.51

293

379

(3024932) HLA-DR beta [Type]

31.58

83.19

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

878

2072

2.17

82.97

1.7

1.6

17.45

11.47

iu/ml

0.44

(3024471) HLA-A [Type]

28.17

82.06

1.0

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

340

479

3.60

81.08

2.2

1.4

1626.67

6128.00

titre

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

578

1138

2.59

80.52

1.4

275.95

284.80

ug/g

0.38

352

660

(3028626) Oxygen [Partial pressure] in Capillary blood

593

1184

2.56

80.40

3.4

2.4

8.24

8.40

kpa

1.19

583

1157

(36660697) Celiac disease serology panel - Serum

1523

4443

1.78

79.10

1.2

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

816

1907

2.19

78.88

1.3

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

768

1750

2.25

78.76

1.3

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

755

1708

2.26

78.71

1.5

1.4

7.34

7.46

u/l

0.10

607

1383

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

584

1175

2.54

78.00

1.3

1.1

—

(3024928) Oxygen saturation in Venous blood

587

1185

2.53

77.88

3.3

1.8

61.83

61.00

0.34

569

1145

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

459

817

2.86

76.75

1.6

—

(3002256) Pathology report gross observation

2386

7915

1.58

76.45

1.3

—

(3036489) Thrombin time

787

1864

2.16

73.64

2.4

1.7

21.11

20.91

0.27

712

1615

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

731

1679

2.23

73.56

2.4

1.9

2.92

2.96

g/l

0.38

671

1526

(3011288) Drugs identified in Urine by Screen method Nominal

812

1956

2.13

72.89

3.7

1.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

712

1624

2.24

72.81

4.0

3.7

1.42

mmol/l

0.05

698

1600

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2121

6924

1.60

72.42

7.7

5.3

—

(3042733) HLA Ab [Presence] in Serum

108

60.53

72.07

5.2

1.7

—

(3008037) Lactate [Moles/volume] in Venous blood

490

939

2.66

71.83

3.3

2.1

1.60

1.73

mmol/l

1.15

475

918

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

475

904

2.67

70.53

1.7

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

655

1464

2.28

70.13

3.7

2.6

66.16

34.37

mg/l

1.09

560

1178

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

564

1179

2.44

69.73

1.3

1.2

549.68

556.58

mg/l

0.05

532

1132

(3034860) Kappa light chains.free [Mass/volume] in Serum

655

1470

2.27

69.49

3.7

2.6

60.28

67.67

mg/l

0.13

559

1187

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

680

1565

2.22

68.09

2.5

2.0

10.39

10.60

g/l

0.43

616

1403

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

667

1523

2.24

68.02

2.6

1.7

93.07

93.45

0.15

650

1454

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

555

1167

2.42

67.79

1.3

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

593

1287

2.35

67.74

3.5

2.5

3.77

15.26

ratio

0.49

349

577

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

582

1263

2.35

66.49

2.2

1.9

12.34

10.90

mg/l

1.03

539

1212

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

604

1334

2.31

66.40

2.9

2.0

190.53

190.49

0.00

577

1269

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

417

764

2.77

66.33

3.8

3.6

1027.75

1119.41

u/ml

0.03

390

698

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

390

691

2.87

65.75

1.9

1.3

—

(3021901) Oxygen saturation in Capillary blood

469

923

2.58

65.39

2.8

2.4

89.62

90.39

1.30

457

902

(3010375) cycloSPORINE [Mass/volume] in Blood

112

9.57

64.70

27.6

11.3

123.72

143.90

ug/l

0.32

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1056

2932

1.85

63.93

3.6

4.60

4.65

pmol/l

0.56

945

2657

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3472

12887

1.42

63.56

1.6

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

665

1561

2.17

63.53

2.5

2.1

1.26

0.83

g/l

1.22

585

1338

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

912

2434

1.92

62.12

2.4

2.2

—

(3020891) Body temperature

963

2627

1.88

61.48

4.6

3.8

36.93

36.89

°c

1.95

951

2602

(3009466) Valproate [Moles/volume] in Serum or Plasma

368

658

2.84

61.10

6.5

4.3

371.79

348.66

umol/l

2.14

329

563

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

496

1039

2.43

61.07

1.3

1.2

3.77

3.72

mmol/l

0.51

466

979

(4146454) Self-monitoring of blood glucose

217

269

4.08

60.98

2.7

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

593

1357

2.23

60.15

1.7

1.5

—

(3047181) Lactate [Moles/volume] in Blood

618

1442

2.18

59.89

6.7

4.0

1.37

1.32

mmol/l

0.46

545

1232

(3004809) Band form neutrophils/Leukocytes in Blood

350

616

2.88

59.71

4.2

2.5

1.54

1.67

0.21

325

553

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

934

2553

1.87

59.25

1.1

0.81

7.37

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

715

1785

2.04

58.51

1.5

9.68

0.24

iu/ml

0.50

128

325

(3023420) DNA double strand Ab [Units/volume] in Serum

765

1969

1.98

57.68

1.7

5.72

7.79

iu/ml

1.08

185

403

(3013139) Helicobacter pylori Ag [Presence] in Stool

1234

3707

1.71

57.44

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

484

1032

2.38

57.43

1.6

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

572

1318

2.21

57.10

1.3

1.4

5.05

9.26

iu/ml

0.95

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

180

201

4.52

57.02

3.0

1.4

—

(3010421) pH of Blood

681

1686

2.06

56.95

4.3

2.5

7.41

1.07

671

1660

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1211

3631

1.71

56.73

2.6

1.9

—

(3049717) Cytology report of Urine Cyto stain

765

1991

1.96

55.92

2.7

2.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

237

338

3.55

55.71

1.9

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

718

1837

1.99

55.02

1.7

279.22

284.01

mu/l

0.16

665

1676

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1261

3857

1.68

54.93

2.5

2.3

20.00

21.35

au/ml

0.24

127

511

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

591

1404

2.14

54.84

1.6

1.5

1.19

1.21

g/l

0.40

562

1351

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

565

1322

2.18

54.39

2.6

2.2

4061.21

2308.41

u/l

0.76

214

285

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

109

7.53

54.12

1.1

1.0

—

(1616796) Gas panel - Central venous blood

496

1103

2.29

53.72

4.0

2.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

573

1356

2.15

53.67

1.6

1.5

0.24

g/l

0.04

546

1300

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

190

235

4.08

53.59

1.3

1.0

83.61

72.77

0.73

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

245

368

3.37

53.57

1.5

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2452

8802

1.45

52.88

2.5

2.1

13.69

14.54

nmol/l

5.50

2244

8215

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

484

1073

2.29

52.78

1.5

1.3

805.32

1114.98

e6/l

0.19

375

804

(3003181) Sodium [Moles/volume] in Urine

366

708

2.62

52.78

1.4

1.3

62.38

63.93

mmol/l

0.25

298

551

(3024522) Salmonella sp identified in Specimen by Organism specific culture

246

375

3.32

52.66

1.5

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

388

776

2.54

52.48

3.3

3.0

0.84

0.79

nmol/l

1.07

312

651

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

406

831

2.48

52.45

1.6

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

479

1065

2.29

51.90

1.5

1.3

30.17

30.18

e6/l

0.00

353

758

(3017354) Segmented neutrophils/Leukocytes in Blood

223

321

3.51

51.79

4.2

2.4

56.41

58.37

0.53

202

280

(3034770) Mitochondria Ab [Titer] in Serum

588

1427

2.10

51.75

1.3

1.2

956.36

1443.53

titre

0.61

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1169

3560

1.69

51.69

1.3

54.33

54.08

au/ml

0.01

286

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

248

386

3.25

51.49

1.5

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

396

810

2.48

51.23

1.2

460.00

440.97

titre

0.04

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

398

819

2.47

50.87

1.2

313.33

89.41

titre

—

(3038515) Glucose [Moles/volume] in Venous blood

406

845

2.44

50.70

3.5

2.1

7.57

7.90

mmol/l

1.16

394

827

(3025941) Bacteria identified in Stool by Culture

1051

3126

1.72

50.56

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

304

546

2.82

50.16

1.2

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

592

1459

2.07

50.09

1.3

1.2

92.69

134.37

titre

1.03

151

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

572

1394

2.09

49.81

2.4

2.0

0.02

g/l

0.17

518

1233

(1001926) Buprenorphine [Presence] in Urine by Screen method

930

2681

1.77

49.76

2.6

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

555

1347

2.10

48.84

2.4

2.0

0.00

g/l

0.50

486

1184

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

318

595

2.71

48.80

3.4

2.8

108.78

269.38

u/ml

0.53

311

586

(3005988) Vibrio sp identified in Specimen by Organism specific culture

235

366

3.25

48.77

1.5

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

234

364

3.25

48.65

1.5

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

234

365

3.24

48.46

1.5

1.2

—

(3037756) Immunofixation for Serum or Plasma

408

870

2.38

48.45

1.6

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

214

314

3.44

48.42

2.0

1.3

—

(3011412) CD3 cells [#/volume] in Blood

209

306

3.45

47.44

2.6

2.1

1270.81

1110.45

e6/l

1.29

186

274

(3015171) Extractable nuclear Ab [Units/volume] in Serum

697

1860

1.91

47.41

1.2

0.64

0.79

u/ml

0.14

187

(4198724) Urine methamphetamine measurement

141

151

4.71

46.78

3.4

1.7

—

(3022621) pH of Urine by Test strip

1366

4439

1.58

46.71

2.6

2.0

6.06

6.07

0.08

935

2829

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1379

4492

1.58

46.68

1.5

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

8.43

46.64

1.1

1.0

—

(40767503) Oxygen content in Capillary blood by calculation

452

1029

2.23

46.44

2.7

2.0

16.34

17.51

9.95

443

1013

(3043409) Potassium [Moles/volume] in Arterial blood

583

1472

2.02

46.30

4.3

3.8

3.92

3.88

mmol/l

1.19

575

1457

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

331

652

2.57

46.16

1.5

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

287

525

2.77

45.89

1.7

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

287

525

2.77

45.89

1.7

1.2

—

(44790047) Parainfluenza type 1 nucleic acid detection

287

525

2.77

45.89

1.7

1.2

—

(44790049) Parainfluenza type 3 nucleic acid detection

287

525

2.77

45.89

1.7

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

154

182

4.27

45.88

2.9

2.1

612.84

517.46

e6/l

0.65

129

145

(3024980) IgG subclass 4 [Mass/volume] in Serum

373

783

2.42

45.80

1.7

0.80

0.97

g/l

1.56

300

591

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

405

886

2.32

45.53

1.5

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

546

1355

2.05

45.39

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

202

300

3.40

44.97

2.9

2.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

155

188

4.16

44.82

3.1

2.1

229.30

267.42

e6/l

0.85

135

158

(3014765) Yersinia sp identified in Stool by Organism specific culture

542

1355

2.03

44.20

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

518

1276

2.06

43.91

2.5

2.0

0.00

g/l

-0.00

485

1181

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1040

3205

1.66

43.88

2.5

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

495

1200

2.10

43.71

1.2

8.18

9.07

u/ml

0.09

150

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

517

1277

2.06

43.52

1.2

11.75

38.78

u/ml

1.52

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

538

1362

2.01

42.43

1.2

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

492

1206

2.07

42.25

1.2

2.36

10.45

u/ml

0.95

(21494815) CD4 cells/Lymphocytes in Specimen

194

293

3.34

42.19

2.4

2.1

38.41

38.93

0.15

194

286

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7347

31796

1.24

41.95

1.9

1.8

1.43

1.37

mmol/l

5.30

6316

26963

(3018572) Chloride [Moles/volume] in Blood

428

995

2.18

41.90

8.0

4.7

105.33

104.96

mmol/l

0.70

390

881

(3039000) Anion gap in Blood by calculation

428

995

2.18

41.90

8.0

4.7

11.46

11.43

mmol/l

0.06

390

881

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

445

1053

2.14

41.74

1.6

1.3

—

(3013290) Carbon dioxide [Partial pressure] in Blood

462

1111

2.11

41.64

4.7

2.8

5.01

4.96

kpa

0.60

452

1084

(3027315) Oxygen [Partial pressure] in Blood

463

1115

2.11

41.59

4.7

2.8

8.59

8.69

kpa

0.48

452

1088

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

180

261

3.48

41.48

1.9

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

289

562

2.60

41.36

1.8

1.3

—

(3012501) Base excess in Blood by calculation

461

1111

2.11

41.33

4.7

2.8

2.55

2.23

mmol/l

1.32

294

710

(3008295) Osmolality of Serum or Plasma

257

470

2.77

41.17

1.3

1.5

280.51

279.54

mosm/kgh2o

0.20

190

364

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

151

193

3.95

41.04

2.9

2.6

40.38

38.40

0.38

102

(3005570) Glucose [Moles/volume] in Urine

199

312

3.22

40.97

1.9

1.5

—

0.08

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

292

574

2.57

40.94

1.8

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

341

725

2.38

40.81

2.0

1.5

1.72

1.86

mmol/l

1.33

333

707

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

400

914

2.22

40.79

1.3

41.14

21.98

u/l

1.51

350

789

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

433

1024

2.15

40.68

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

433

1025

2.14

40.59

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

279

539

2.62

40.44

3.0

1.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

411

955

2.18

40.30

1.2

5.25

7.12

u/ml

0.14

(3044927) Protein electrophoresis panel - Urine

206

335

3.11

40.12

1.1

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

213

356

3.02

39.73

4.9

3.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

381

865

2.23

39.45

1.1

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5963

25376

1.25

38.85

4.2

4.0

21.55

21.88

0.80

2688

11375

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

14927

69854

1.23

38.72

22.4

11.8

333.38

334.02

g/l

12.55

14837

69299

(3044290) Cell count panel - Cerebral spinal fluid

439

1068

2.09

38.46

1.5

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

1142

3725

1.57

38.29

2.5

1.4

—

(3016879) Cocaine [Presence] in Urine

1078

3474

1.59

38.03

2.6

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

678

1942

1.78

37.03

1.6

1.7

15.62

16.93

u/ml

0.21

159

706

(3003327) Ova and parasites identified in Stool by Light microscopy

688

1984

1.76

36.74

1.8

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

178

280

3.21

36.52

1.8

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

178

280

3.21

36.52

1.8

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

178

280

3.21

36.52

1.8

1.2

—

(3003129) Base excess in Capillary blood by calculation

247

473

2.64

36.44

2.2

1.5

0.26

0.71

mmol/l

0.99

239

462

(3028300) Cannabinoids [Presence] in Urine

1148

3794

1.55

36.33

2.5

1.4

—

(3027008) Opiates [Presence] in Urine

1146

3786

1.55

36.33

2.3

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

206

357

2.91

36.26

2.1

2.4

21.29

18.66

nmol/l

2.36

196

336

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

233

436

2.70

35.88

1.5

1.6

311.84

435.24

mu/l

1.12

189

337

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

185

303

3.08

35.69

1.1

289.55

272.58

mg/l

0.39

162

263

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

249

485

2.60

35.59

1.1

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

206

362

2.87

35.43

1.1

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

623

1767

1.79

35.15

1.3

228.54

219.98

miu/ml

0.20

263

845

(1761482) Bacteria [#/volume] in Urine by Culture

440

1112

2.01

34.92

4.4

2.6

—

(3027944) Amphetamines [Presence] in Urine

1129

3760

1.53

34.51

2.4

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

493

1306

1.92

34.31

2.2

1.8

130.63

137.04

g/l

6.03

396

1026

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

350

815

2.17

34.21

1.4

4.46

14.14

u/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

219

407

2.72

34.17

4.4

3.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

6.62

34.04

1.9

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

189

325

2.94

33.73

1.2

1.1

43.95

52.13

mg/l

0.83

157

273

(3017569) Oxygen content in Arterial blood

124

159

3.93

33.66

2.5

16.36

16.45

0.08

124

159

(3000475) Leukocytes [#/volume] in Synovial fluid

501

1344

1.89

33.61

1.6

17741.96

12969.75

e6/l

0.71

343

965

(3003434) Protein [Mass/volume] in Pleural fluid

290

627

2.34

33.57

1.5

1.4

32.14

33.42

g/l

0.82

259

572

(3020876) Protein [Mass/time] in 24 hour Urine

239

471

2.56

33.44

2.5

2.1

1.53

1.38

g/24h

0.22

149

270

(3016650) Hepatitis A virus Ab [Presence] in Serum

375

907

2.09

33.39

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

134

184

3.67

33.34

2.2

1.9

7.67

7.60

mmol/l

0.07

134

184

(3000034) Microalbumin [Mass/volume] in Urine

183

311

2.97

33.31

3.1

2.6

71.12

26.90

mg/l

0.78

137

212

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

316

713

2.24

33.26

1.1

1.49

g/l

0.03

288

654

(3052851) Hemolysis interference index of Serum or Plasma

521

1427

1.85

32.84

3.4

2.8

1.99

2.19

index

0.24

292

616

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

324

744

2.20

32.75

1.2

4.81

3.48

u/ml

0.72

151

356

(3024666) Lithium [Moles/volume] in Serum or Plasma

143

210

3.43

32.49

13.3

11.4

0.61

mmol/l

0.01

130

189

(3020961) Endomysium IgA Ab [Titer] in Serum

903

2899

1.59

32.33

1.1

172.84

225.97

titre

0.43

108

(1175426) CD3 cells/Lymphocytes in Blood

160

256

3.15

32.06

2.2

1.9

73.20

72.74

0.12

152

245

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

249

515

2.44

31.67

1.7

1.9

19.31

27.72

ug/l

1.62

244

508

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

154

243

3.20

31.52

2.2

1.9

14.61

16.15

0.87

149

234

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

123

166

3.73

31.33

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

279

612

2.30

31.32

3.0

2.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

173

296

2.95

31.17

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

327

770

2.15

31.15

1.8

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

8.34

30.99

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

123

169

3.67

30.62

1.3

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

135

199

3.42

30.54

1.1

4.37

9.35

nmol/l

0.75

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1140

3910

1.49

30.32

1.2

128.90

148.46

u/ml

0.86

415

1627

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

257

552

2.35

30.23

1.1

—

(40768446) Kidney Pathology biopsy report

104

127

4.13

29.99

1.9

1.0

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

219

437

2.53

29.96

1.3

1.4

2.91

3.13

g/l

0.89

161

291

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

216

429

2.54

29.83

1.1

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

328

789

2.10

29.67

1.2

3.76

4.74

u/ml

0.31

117

311

(3024139) IgG subclass 3 [Mass/volume] in Serum

218

437

2.52

29.57

1.3

1.4

0.39

0.43

g/l

0.57

159

291

(3027135) IgG subclass 1 [Mass/volume] in Serum

218

437

2.52

29.57

1.3

1.4

6.66

7.17

g/l

0.96

161

291

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

104

129

4.06

29.45

2.2

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

104

129

4.06

29.45

2.2

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

104

129

4.06

29.45

2.2

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

104

129

4.06

29.45

2.2

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

262

578

2.29

29.08

1.3

1.2

—

(4062490) Immunoglobulin typing, IgG

215

432

2.51

29.03

1.3

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.57

28.84

2.6

1.7

0.62

mmol/l

0.03

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

100

125

4.03

28.07

2.6

2.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

695

2167

1.63

28.00

1.5

1.3

21.60

28.70

iu/l

6.83

575

1851

(3004616) Nuclear Ab [Presence] in Serum

222

462

2.43

27.95

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

244

531

2.32

27.93

1.1

18.00

17.81

u/ml

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

356

905

1.99

27.90

2.0

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

148

247

3.02

27.83

2.2

1.9

—

(40768441) Liver Pathology biopsy report

155

267

2.93

27.68

1.5

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

172

315

2.75

27.66

1.3

1.1

1.99

2.02

mmol/l

0.15

161

292

(21494755) Public health laboratory ask at order entry panel

1749

11459

0.75

27.29

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

110

152

3.65

27.23

2.6

1.4

126.16

83.82

umol/l

0.89

(3000012) Reticulocyte production index

285

677

2.13

26.65

2.0

2.1

0.89

0.91

0.32

206

414

(3045142) Bone marrow Pathology biopsy report

222

474

2.36

26.51

1.4

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

111

159

3.52

26.20

1.8

1.4

28.22

28.14

umol/l

0.02

102

141

(40761536) Microorganisms panel - Urine sediment

1470

5430

1.38

26.18

4.3

2.8

—

(21494434) Karyotype in Bone marrow

177

341

2.62

25.98

1.2

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

108

4.15

25.91

1.4

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

108

4.15

25.91

1.4

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4482

19164

1.22

25.89

3.1

2.9

0.76

0.78

ug/l

0.35

2778

10996

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

326

826

2.00

25.82

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

211

446

2.39

25.76

1.5

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

809

2672

1.54

25.64

2.0

1.8

214.13

217.33

pmol/l

0.32

771

2573

(4027681) Cerebrospinal fluid IgG ratio and IgG index

143

246

2.93

25.63

1.2

0.54

0.69

ratio

2.22

123

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.90

25.46

3.5

2.8

2.10

2.30

ratio

0.21

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

376

1011

1.88

25.16

1.2

63.56

45.47

u/ml

0.65

(3000093) Morphology [Interpretation] in Blood Narrative

208

442

2.38

25.12

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

254

590

2.17

25.11

1.2

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

101

140

3.63

24.94

1.9

1.4

1.92

1.98

umol/l

0.27

121

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

502

1480

1.72

24.94

1.1

3.90

3.72

0.16

313

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

439

1246

1.78

24.81

2.1

1.4

0.90

0.85

nmol/l

0.65

376

1115

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

101

4.19

24.74

2.6

3.6

129.54

420.07

pmol/l

0.31

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1022

3571

1.46

24.74

2.1

1.8

37.73

39.29

nmol/l

1.42

994

3527

(3008536) Aspergillus sp Ab [Presence] in Serum

5.80

24.54

2.1

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

248

577

2.17

24.43

1.4

1654.53

3440.80

e6/l

2.11

176

404

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

303

764

2.00

24.34

1.1

113.76

116.20

0.67

282

688

(3020191) Ethanol [Moles/volume] in Serum or Plasma

208

449

2.34

24.31

1.5

1.2

1.38

1.22

promille

0.65

162

352

(3008898) HLA-B27 [Presence]

662

2114

1.59

24.26

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

189

392

2.43

24.04

1.1

1.0

282.19

282.63

mg/l

0.02

172

359

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

199

425

2.36

23.81

1.3

1.2

381.09

509.81

u/l

0.71

188

400

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.31

23.79

2.5

1.1

32108.13

1808.08

u/ml

0.50

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.48

23.72

1.8

1.7

16.43

14.67

umol/l

0.45

(3027923) C peptide [Moles/volume] in Serum or Plasma

133

230

2.91

23.68

1.5

1.33

1.18

nmol/l

0.71

101

189

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

470

1385

1.72

23.41

2.0

1.9

16.48

4.01

iu/l

0.51

190

592

(3019420) Tryptase [Mass/volume] in Serum or Plasma

115

183

3.17

23.37

1.3

1.7

7.80

9.35

ug/l

0.31

167

(3017704) Immunofixation for Urine

121

199

3.06

23.37

1.5

1.3

—

(40768443) Skin Pathology biopsy report

805

2713

1.51

23.27

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

914

3166

1.47

23.13

1.3

1.4

—

(4195642) Thrombophilia screening test

299

765

1.98

23.11

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

119

3.77

23.07

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

940

3277

1.46

23.02

1.1

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.14

23.01

2.5

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.14

23.01

2.5

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

184

385

2.41

23.00

1.1

1.2

61.86

60.06

u/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

135

240

2.83

22.95

1.1

1.10

1.09

u/l

0.09

103

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

130

228

2.87

22.63

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

100

4.03

22.55

2.5

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

126

219

2.90

22.27

1.7

1.2

1354149.00

2848704.56

iu/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

565

1774

1.61

22.21

1.3

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

209

472

2.23

22.13

2.5

1.6

19.17

30.02

mg/l

2.54

172

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

516

1585

1.65

22.10

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1789

6984

1.31

22.08

1.5

1.4

—

(3014271) Vancomycin [Susceptibility]

104

161

3.25

22.06

2.9

2.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

156

308

2.55

21.94

1.5

1.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

241

580

2.10

21.91

1.1

99.13

100.53

0.32

228

549

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

162

328

2.49

21.69

1.8

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

145

3.37

21.65

1.9

1.8

154.32

152.40

0.06

139

(3038026) Centromere Ab [Units/volume] in Serum

134

246

2.74

21.57

1.1

1.2

74.20

57.65

u/ml

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

123

215

2.88

21.55

2.2

1.7

—

(3012441) Differential panel - Pleural fluid

217

505

2.17

21.44

1.4

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

257

642

2.02

21.24

1.4

1.2

0.35

0.36

nmol/l

0.02

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

208

478

2.20

21.18

4.3

3.4

30.42

44.17

u/ml

0.66

203

454

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

178

382

2.35

21.14

1.6

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

214

500

2.16

20.95

1.4

1.2

6.37

5.96

mmol/l

1.27

200

460

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

107

3.76

20.77

2.6

1.6

28.79

29.36

0.12

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

153

310

2.49

20.48

1.4

1.3

14.12

11.68

u/l

3.28

144

303

(3043410) Blood group antigens tested for on Red Blood Cells

3.86

20.41

1.3

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

304

818

1.88

20.40

2.0

5.04

5.54

mmol/24h

1.53

267

751

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

172

371

2.34

20.23

1.7

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

126

232

2.74

20.21

1.5

1.4

8.33

6.52

u/l

0.54

108

195

(4268621) Lupus anticoagulant assay

225

547

2.08

19.99

2.3

2.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.12

19.76

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

207

489

2.14

19.76

1.3

1.4

20.93

28.99

u/l

2.93

170

404

(3006653) Thiamine [Moles/volume] in Blood

117

211

2.79

19.49

1.2

142.46

131.83

nmol/l

1.39

117

211

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

220

539

2.06

19.18

1.4

1.2

0.19

0.20

nmol/l

0.22

180

415

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

250

643

1.96

19.14

1.4

1.2

0.62

5.47

nmol/l

0.86

243

622

(3016244) Insulin [Units/volume] in Serum or Plasma

127

243

2.63

19.03

3.5

3.2

24.97

28.07

mu/l

0.40

120

228

(3006245) CD3-CD19+ cells/cells in Blood

123

3.40

18.82

2.8

2.0

9.97

10.34

0.06

113

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

113

204

2.79

18.80

1.9

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

113

204

2.79

18.80

1.9

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

158

340

2.34

18.72

1.4

1.2

2.27

3.15

u/ml

0.29

155

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.71

18.66

1.8

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

212

519

2.06

18.54

1.4

55231.69

51351.53

e6/l

0.06

128

299

(3045788) Cell count panel - Pleural fluid

201

483

2.10

18.43

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

432

1332

1.64

18.31

2.5

2.1

121.04

79.52

ug/min

0.86

256

810

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

426

1309

1.65

18.30

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

142

294

2.43

18.26

1.4

1.6

22.12

25.08

u/ml

0.31

(3022493) Free Hemoglobin [Mass/volume] in Plasma

101

174

2.92

18.21

4.7

1.2

62.90

8578.10

mg/l

1.83

102

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

214

531

2.03

18.09

1.4

1.3

1.45

1.50

nmol/l

0.20

194

485

(40768806) Pleura Pathology biopsy report

208

511

2.05

18.04

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

197

475

2.09

17.93

2.3

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

101

176

2.89

17.88

2.7

1.3

134.69

86.49

ng/l

3.16

101

176

(3016038) Potassium [Moles/volume] in Urine

133

270

2.48

17.81

1.3

1.2

38.15

38.05

mmol/l

0.02

121

247

(3005532) Lymphocytes/Leukocytes in Pleural fluid

143

3.10

17.44

1.4

1.3

61.99

59.75

0.19

118

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

276

759

1.84

17.41

1.1

—

(3023410) Appearance of Cerebral spinal fluid

213

536

2.00

17.36

1.7

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

583

1956

1.51

17.29

1.2

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

+∞

17.15

1.2

0.0

64.91

—

ug/l

—

(3028433) Virus identified in Specimen by Culture

3.70

17.13

1.3

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

139

295

2.37

17.01

1.2

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

151

333

2.28

17.00

1.9

1.5

4.49

3.31

mg/l

2.45

146

314

(3004451) EKG impression Narrative

124

250

2.50

16.86

1.3

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

167

387

2.17

16.79

1.6

1.3

13.29

12.07

umol/l

1.27

157

367

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

125

254

2.48

16.74

1.4

1.2

457.00

514.40

titre

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

157

355

2.23

16.72

1.2

105.51

111.45

pmol/l

0.75

157

355

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

103

190

2.73

16.56

4.9

3.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

144

315

2.30

16.52

1.6

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

238

635

1.89

16.48

1.4

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

3.67

16.46

2.5

1.7

0.20

4.64

e9/l

0.64

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

188

461

2.06

16.44

1.2

1.1

66.77

71.57

u/l

0.17

165

393

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

105

197

2.68

16.38

1.2

73.73

77.72

0.14

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

183

445

2.07

16.35

1.2

169.00

205.75

titre

0.23

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

183

445

2.07

16.35

1.2

213.33

317.00

titre

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

140

304

2.32

16.33

1.2

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

128

3.14

16.27

1.4

1.2

114.99

136.79

nmol/l

0.46

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

116

231

2.53

16.18

1.2

—

(3042517) Benzodiazepines panel - Urine

8.38

16.16

2.3

2.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

126

3.15

16.15

2.4

1.7

918.30

1738.23

e6/l

0.60

(3039162) Centromere protein B Ab [Units/volume] in Serum

213

552

1.95

16.06

1.3

1.2

58.76

58.82

u/ml

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

226

2.54

16.05

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

210

542

1.95

16.01

1.4

1.2

—

nmol/l

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

120

245

2.47

15.94

1.4

1.2

72.50

137.69

titre

0.28

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

4.29

15.89

2.0

2.2

1.19

1.14

mmol/l

0.05

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

3.07

15.72

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

125

263

2.39

15.62

8.8

3.7

214.22

3534.29

u/ml

0.49

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

108

212

2.56

15.51

3.4

2.8

1.11

1.24

0.29

108

212

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

190

479

2.00

15.47

1.5

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

112

3.23

15.30

1.4

1.3

39.48

41.48

g/l

1.51

112

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

122

257

2.39

15.22

1.2

93.20

80.50

u/l

0.71

102

217

(3016750) Collection duration of Urine

120

251

2.41

15.20

2.4

1.7

500.94

506.61

min

0.23

170

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

603

2097

1.46

15.05

3.2

2.6

63.65

52.29

u/ml

0.40

580

2039

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.94

14.95

1.2

1.1

1000.00

1030.77

titre

—

(3029396) Erythrocyte agglutination [Presence] in Blood

5.84

14.91

3.1

1.5

—

(3004775) Volume in Urine collected for unspecified duration

150

351

2.15

14.80

2.4

1.8

653.34

649.18

0.04

216

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

112

230

2.45

14.74

2.4

2.6

147.28

135.89

nmol/l

0.56

100

203

(3006922) Hepatitis E virus Ab [Presence] in Serum

170

419

2.04

14.73

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

119

252

2.38

14.70

1.2

20.35

23.21

u/l

0.36

207

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

122

262

2.34

14.63

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

170

421

2.03

14.55

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.80

14.51

1.7

1.4

—

(40765096) Chromosome analysis panel by Banding

119

3.09

14.48

1.2

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

5.03

14.47

1.6

1.5

232360.75

682866.12

nmol/l

0.34

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

337

1040

1.64

14.35

1.1

70.33

1047.96

iu/ml

0.53

194

(3028679) Herpes simplex virus Ab [Presence] in Serum

117

249

2.37

14.32

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

131

294

2.24

14.27

1.6

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.32

14.16

1.5

1.2

92.50

86.73

0.42

(4015189) Microbial culture of sputum

3.81

14.11

2.8

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

167

419

2.01

13.84

1.1

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

148

355

2.10

13.78

1.3

1.2

12.61

15.32

u/l

0.79

135

335

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

5.17

13.75

1.3

1.1

1.18

1.16

mmol/l

0.53

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

470

1584

1.50

13.74

1.1

7.15

5.67

eliau/ml

0.27

277

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

102

3.20

13.68

1.1

90.31

93.11

0.24

(3006576) Bicarbonate [Moles/volume] in Blood

141

2.82

13.54

6.6

5.0

24.99

24.61

mmol/l

0.31

130

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

675

4594

0.73

13.37

1.1

0.67

0.65

ratio

0.29

510

(3001893) Eosinophils/Leukocytes in Pleural fluid

140

2.80

13.25

1.4

1.3

2.41

4.06

0.69

117

(3032057) Clostridioides difficile [Presence] in Stool

4.24

13.04

2.1

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

127

293

2.18

13.02

1.7

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

147

360

2.06

13.01

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

156

393

2.00

12.82

1.9

1.8

1.34

1.48

u/field

0.15

225

(3047007) Chlamydophila sp Ab [Presence] in Serum

284

866

1.65

12.72

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

105

225

2.35

12.72

1.8

1.2

22.68

26.49

umol/l

0.53

203

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

4.22

12.69

1.1

1.2

41.76

48.01

mg/l

0.23

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

268

808

1.67

12.53

1.1

2.42

2.43

0.01

190

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

129

305

2.13

12.49

1.0

256.37

364.76

ng/l

2.90

238

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

256

763

1.69

12.49

1.6

1.4

0.27

nmol/l

0.01

191

580

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

129

306

2.12

12.40

1.0

756.54

693.49

ng/l

0.61

227

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

129

306

2.12

12.40

1.0

37.99

45.45

ng/l

0.85

238

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.51

12.27

1.4

1.2

26.10

26.25

g/l

0.02

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.16

12.19

6.9

5.1

5.99

6.14

kpa

0.60

(21491868) Cryoglobulin [Mass/volume] in Serum

150

2.65

12.18

1.2

0.08

0.14

g/l

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

122

2.84

12.07

1.4

1.3

26.93

27.39

0.04

107

(21494814) CD8 cells/Lymphocytes in Specimen

151

2.63

12.04

1.8

2.1

31.32

31.71

0.07

151

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

128

2.79

12.02

1.2

0.29

0.30

g/l

0.69

(3026692) Albumin [Mass/volume] in Peritoneal fluid

103

3.03

12.01

1.5

1.2

12.21

11.92

g/l

0.08

(3001186) Copper [Moles/volume] in Serum or Plasma

117

2.88

11.97

1.2

1.1

15.90

15.94

umol/l

0.03

100

(40757373) Influenza virus identified in Isolate

3.49

11.95

1.9

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

191

2.42

11.94

1.1

1.0

202.82

240.11

ng/l

0.10

(3011985) Renin [Units/volume] in Plasma

264

805

1.65

11.86

1.4

1.5

71.30

74.81

mu/l

0.05

238

747

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

220

638

1.74

11.85

1.3

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

115

2.89

11.84

1.1

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

103

227

2.28

11.78

2.2

1.7

27.76

48.96

umol/l

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

124

2.80

11.75

1.3

1.2

105.07

112.76

1.04

110

(3006571) Granulocytes/Leukocytes in Synovial fluid

218

633

1.74

11.69

1.6

1.5

59.57

54.50

0.94

145

404

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

104

231

2.27

11.69

1.1

1453.08

1479.29

miu/ml

0.08

104

231

(3040151) Glucose [Moles/volume] in Capillary blood

235

698

1.70

11.64

5.8

4.9

7.02

7.38

mmol/l

0.89

201

575

(3035880) pH of Pleural fluid

112

258

2.18

11.58

1.4

1.2

7.38

7.39

0.13

176

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.23

11.58

7.0

4.5

5.45

5.38

kpa

0.07

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

114

2.87

11.55

1.1

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

9.13

11.36

1.2

1.0

20.14

11.17

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

4.62

11.35

1.3

1.2

852.92

143.28

u/l

0.40

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

743

4868

0.76

11.34

1.2

1.1

0.90

g/l

0.15

743

4853

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

329

1072

1.55

11.31

1.1

18.39

13.61

au/ml

0.67

391

(40758292) HTLV I+II Ab panel - Serum

3.35

11.31

1.4

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

102

2.96

11.23

1.1

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

158

2.51

11.08

1.1

1.0

12.75

11.03

u/ml

0.22

104

(3026470) Cobalt [Mass/volume] in Blood

105

240

2.20

11.08

2.2

2.3

3.01

3.06

ug/l

0.03

219

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

330

1082

1.54

11.05

1.1

1.2

1.09

1.34

0.23

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

115

2.80

10.93

2.2

1.6

28728.78

3087.02

e6/l

0.49

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

142

368

1.94

10.88

1.1

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

107

2.87

10.86

1.1

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.92

10.85

1.2

90.15

142.48

ng/l

0.36

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

2.83

10.83

1.1

1.0

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

146

384

1.91

10.73

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

142

370

1.93

10.72

1.1

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

186

2.35

10.67

1.6

2789.33

3044.71

titre

0.09

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

100

228

2.21

10.64

2.1

2.2

158.80

86.98

ug/min

0.39

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

141

368

1.93

10.60

1.1

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

153

411

1.87

10.58

6.1

5.7

41.67

118.51

u/ml

1.58

139

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

19.08

10.56

3.5

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

121

2.70

10.45

1.2

22.14

16.67

—

(40768793) Breast Pathology biopsy report

294

956

1.55

10.25

1.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

5.71

10.22

1.0

0.05

0.84

u/ml

0.69

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

245

764

1.62

10.17

1.4

336.95

286.72

pmol/l

0.83

211

671

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

136

356

1.92

10.16

1.1

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

135

2.57

10.14

1.4

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

7.03

10.10

1.3

1.5

40.76

34.80

umol/l

0.43

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

188

2.30

10.08

1.1

1.0

—

(3044007) Cell count panel - Peritoneal fluid

115

2.71

10.05

2.0

1.7

—

(3025577) Chromium [Mass/volume] in Blood

102

241

2.13

10.00

2.2

2.3

2.05

2.04

ug/l

0.01

202

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.59

9.98

1.1

1.2

0.80

0.58

umol/24h

1.95

(4094501) Cardiovascular stress test using bicycle ergometer

520

1902

1.38

9.96

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

170

482

1.78

9.96

3.5

2.8

12.45

13.63

index

0.60

117

240

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

113

2.71

9.92

1.1

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

137

363

1.90

9.90

1.1

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

174

2.34

9.87

2.7

1.45

1.19

ug/l

0.31

162

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

111

2.72

9.78

1.3

1.6

9.26

8.48

ug/l

0.63

111

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

140

376

1.87

9.73

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

176

2.31

9.64

1.1

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

148

2.45

9.63

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.77

9.58

2.3

1.9

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

5.78

9.51

3.2

2.9

1.06

1.24

mg/l

0.16

(3010144) Erythrocytes [#/volume] in Synovial fluid

186

551

1.70

9.41

1.3

1.4

143802.61

82090.87

e6/l

0.51

129

370

(3018333) Ribosomal P Ab [Presence] in Serum

132

352

1.89

9.39

1.1

1.2

—

(3035715) Granulocytes [#/volume] in Blood

349

1203

1.46

9.30

3.8

3.0

4.16

4.03

e9/l

0.46

349

1203

(40768795) Lymph node Pathology biopsy report

182

539

1.70

9.23

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.10

9.13

2.5

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

3.47

9.10

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

429

1544

1.40

9.08

3.7

3.0

57.83

57.64

0.11

429

1544

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

234

2.09

9.08

2.2

2.6

49.26

53.24

umol/l

0.60

201

(3035947) Staphylolysin Ab [Units/volume] in Serum

241

2.07

9.05

1.2

1.1

4.11

5.05

iu/ml

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.94

8.99

1.2

1.1

9.49

8.48

pmol/l

0.15

(3023383) Lactate [Moles/volume] in Pleural fluid

120

2.56

8.92

1.6

1.2

3.32

4.03

mmol/l

0.70

111

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

151

429

1.77

8.85

1.4

3.05

4.88

ug/l

0.98

133

357

(3034426) Prothrombin time (PT)

139

2.42

8.83

1.3

1.2

29.78

27.61

1.35

139

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

105

266

1.99

8.67

1.5

6.25

4.74

u/l

0.49

197

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

239

2.04

8.62

1.5

1.8

4.00

2.43

u/field

0.41

193

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

+∞

8.58

8.3

0.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.38

8.57

1.1

1.0

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

3.04

8.52

1.4

1.2

24.44

21.02

0.29

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

435

1588

1.38

8.50

1.1

2.66

2.60

u/ml

0.04

247

739

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

238

2.03

8.41

1.7

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.14

8.36

1.2

1.0

0.15

0.46

u/ml

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.00

8.34

1.4

1.1

96.00

88.49

0.68

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.45

8.33

1.3

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.24

8.29

1.2

1.0

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

3.24

8.27

1.7

1.3

7.68

8.61

0.12

(3018133) Calcium [Moles/volume] in Urine

2.90

8.26

2.4

1.7

2.99

2.58

mmol/l

0.47

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

110

2.56

8.25

1.2

122.30

267.20

ug/l

0.49

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

237

2.02

8.20

1.4

1.2

—

(4034850) Laboratory test

483

3204

0.75

8.16

10.4

8.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.26

8.15

2.2

1.7

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

6.46

8.15

1.0

—

(3024263) Appearance of Synovial fluid

102

262

1.96

8.14

1.7

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.91

8.13

1.3

1.2

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

4.02

8.09

1.2

1.3

60.60

56.50

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

122

334

1.84

8.09

2.0

1.7

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

228

2.03

8.09

1.8

1.4

3.67

5.44

nmol/l

0.26

192

(3015956) Eosinophils/Leukocytes in Blood by Manual count

3.03

8.09

2.6

1.8

2.16

2.87

0.54

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.92

8.00

1.2

1.1

77.00

81.57

0.13

(3007463) Buprenorphine [Presence] in Urine

15.07

7.87

5.2

12.8

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.93

7.87

1.3

1.1

1.48

1.61

mmol/l

0.25

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

3.06

7.83

8.1

5.2

10.67

11.07

0.47

(3036670) Protein [Mass/volume] in Synovial fluid

126

2.39

7.76

1.2

1.3

39.52

41.13

g/l

0.38

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

218

2.03

7.76

1.1

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

388

1413

1.39

7.74

1.1

5.97

5.86

u/ml

0.04

229

678

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.84

7.67

1.3

1.2

80.54

87.87

0.31

(4038314) Semen analysis, post vasectomy

3.54

7.66

1.2

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

230

1.99

7.62

1.2

1.1

24.33

20.76

u/l

0.30

202

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.29

7.59

1.2

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

153

458

1.68

7.56

1.4

1.2

9.02

8.94

mmol/l

0.07

147

428

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

103

273

1.90

7.56

7.6

7.9

321.66

56.43

ug/l

0.70

192

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.88

7.49

2.3

1.3

1.31

umol/l

0.02

(3010726) Horse dander IgE Ab [Units/volume] in Serum

373

1358

1.39

7.47

1.1

1.68

2.19

u/ml

0.58

208

571

(3006270) Folate [Moles/volume] in Blood

135

394

1.72

7.31

1.2

1.1

374.70

387.96

nmol/l

0.23

119

345

(3041672) Baker's yeast Ab [Presence] in Serum

8.22

7.31

1.1

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

234

1.96

7.29

1.2

1.1

83.32

84.68

u/l

0.05

202

(3045683) HLA typing for celiac disease panel - Blood or Tissue

113

313

1.82

7.27

1.0

—

(3014891) Appearance of Pleural fluid

3.25

7.27

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.28

7.16

1.2

1.97

1.63

umol/24h

0.95

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.01

7.09

1.3

1.2

2.28

2.16

mmol/l

0.02

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.95

7.04

1.1

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

+∞

7.02

8.8

0.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

377

1391

1.37

6.99

1.1

1.37

1.14

u/ml

0.19

176

543

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.02

6.97

3.7

1.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.02

6.97

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.71

6.91

1.1

1.3

12.66

8.51

u/ml

0.13

(3001556) Androgen free Index in Serum or Plasma

3.57

6.78

1.2

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

179

2.05

6.68

3.1

30.40

28.82

umol/l

0.51

139

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

672

2704

1.26

6.66

1.9

1.4

5.18

3.48

mg/l

1.06

492

1849

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.72

6.64

1.4

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2107

11872

0.88

6.63

2.0

3.69

3.65

ratio

0.72

1665

9182

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

109

308

1.78

6.63

1.2

1.07

1.08

ratio

0.32

246

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

218

1.94

6.60

3.5

2.3

75.35

109.71

au/ml

0.44

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.49

6.49

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

218

739

1.49

6.47

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1552

8912

0.86

6.46

1.7

3.48

3.57

mmol/l

2.10

1105

6046

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.11

6.44

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

224

1.91

6.41

1.0

1.1

96.90

98.20

0.15

167

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

186

2.00

6.36

1.1

1.0

11.43

4.74

u/ml

0.85

(37021550) Renin [Units/volume] in Plasma --upright

2.51

6.35

1.3

1.2

71.36

43.95

mu/l

0.55

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

+∞

6.24

1.1

0.0

1.42

—

mom

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

+∞

6.24

1.0

0.0

0.03

—

u/ml

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

5.36

6.23

5.5

2.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.31

6.14

1.2

1.0

22.56

23.16

u/l

0.03

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.92

6.04

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

219

1.88

5.98

1.7

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

104

2.32

5.91

1.8

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

3.39

5.90

1.0

1.2

0.78

2.90

u/ml

1.07

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.02

5.88

1.1

1.0

—

(1002224) Polysomnography panel

1007

4281

1.19

5.86

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

124

2.19

5.85

1.5

1.7

16.80

14.99

pmol/l

0.44

108

(3012565) Volume of 24 hour Urine

272

1.77

5.84

2.7

2.0

2009.59

2171.61

0.77

250

(3005082) Progesterone [Moles/volume] in Serum or Plasma

121

2.20

5.82

1.3

34.99

32.00

nmol/l

0.24

111

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.71

5.82

3.5

1.9

24.95

29.61

mg/l

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.82

5.72

2.1

1.4

15.26

53.21

pmol/l

1.34

(3020491) Glucose [Moles/volume] in Blood

132

414

1.60

5.58

2.2

1.9

6.80

7.01

mmol/l

0.40

322

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

114

2.20

5.52

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

256

924

1.40

5.52

1.1

2.61

2.55

eliau/ml

0.05

109

549

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.99

5.51

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

293

1083

1.36

5.48

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

267

1.75

5.45

4.5

3.0

8.58

9.46

mg/l

0.65

211

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.84

5.45

1.2

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

3.26

5.37

1.0

1.24

0.09

u/ml

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.45

5.34

1.0

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

3.04

5.25

1.0

0.04

0.83

u/ml

0.49

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.59

5.25

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

104

2.22

5.20

1.1

267.50

298.51

pmol/l

0.28

(3011841) English Walnut IgE Ab [Units/volume] in Serum

3.17

5.18

1.0

1.3

2.25

7.93

u/ml

0.87

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.80

5.15

1.3

3.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.68

5.12

3.7

2.5

40.50

44.63

umol/l

0.44

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.97

5.08

1.0

0.02

0.32

u/ml

0.90

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

229

1.78

5.03

3.4

1.6

420.47

304.16

ug/l

0.11

216

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.75

5.00

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

2.29

4.97

1.2

1.3

138.23

139.14

mmol/l

0.50

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

9.21

4.91

1.3

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.38

4.89

1.4

1.6

0.34

0.41

ug/l

0.44

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

282

1057

1.34

4.88

1.0

0.32

0.45

u/ml

0.35

107

234

(3003329) Lymphocytes/Leukocytes in Synovial fluid

166

567

1.47

4.87

1.5

28.36

32.35

0.69

108

375

(3036071) Salmonella sp Ab [Titer] in Serum

202

1.82

4.86

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.01

4.81

1.1

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

115

2.10

4.77

1.4

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

226

1.76

4.74

2.3

2.0

9.13

9.44

mg/l

0.18

182

(3032868) Hemoglobin electrophoresis panel in Blood

2.65

4.70

1.4

1.5

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.02

4.70

1.7

2.40

2.57

mg/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.04

4.68

1.5

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.62

4.66

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

113

2.09

4.64

1.1

1.2

7.75

0.86

u/ml

0.63

107

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

208

749

1.40

4.63

1.3

1.1

7.13

7.35

mmol/l

0.54

186

642

(3012494) Peanut IgE Ab [Units/volume] in Serum

124

2.03

4.57

1.1

1.25

5.68

u/ml

0.52

(3014133) Dog dander IgE Ab [Units/volume] in Serum

320

1235

1.30

4.56

1.1

3.00

4.07

u/ml

0.79

177

542

(3033099) Centromere Ab [Titer] in Serum

2.32

4.51

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

101

2.14

4.50

3.0

3.3

7.93

147.03

ug/l

0.67

101

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

157

540

1.46

4.48

1.1

19.48

24.38

u/ml

0.73

243

(37208534) Antinuclear antibody arbitrary concentration in serum

150

1.91

4.44

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

123

2.00

4.35

1.3

0.22

0.48

mmol/l

—

(3028717) Thiamine [Mass/volume] in Blood

2.43

4.31

1.3

1.0

63.90

67.06

ug/l

0.25

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

368

1459

1.27

4.29

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.44

4.29

2.3

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

2.67

4.28

1.0

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

227

1.70

4.22

1.1

1.2

15.13

24.83

u/ml

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

190

1.77

4.19

2.6

2.3

10.43

10.47

kpa

0.03

190

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

190

1.77

4.19

2.6

2.3

4.80

4.87

kpa

0.19

190

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

253

958

1.33

4.16

1.4

250.07

129.46

pmol/l

1.02

248

940

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

122

1.98

4.14

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

122

1.98

4.14

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

122

1.98

4.14

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

122

1.98

4.14

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

259

1.65

4.14

1.3

1.2

184.58

182.63

mmol/24h

0.06

259

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

147

1.88

4.13

1.4

1.3

31.47

40.74

0.97

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

373

1490

1.26

4.10

1.6

1.5

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.77

4.10

1.7

1.18

1.52

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.77

4.10

1.7

1.28

4.04

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.77

4.10

1.7

0.45

0.94

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.77

4.10

1.7

1.51

1.62

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.77

4.10

1.7

2.65

0.91

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.77

4.10

1.7

0.48

3.91

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.77

4.10

1.7

3.79

2.21

mg/l

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.39

4.04

6.9

3.8

52.04

31.33

ug/min

0.89

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.68

4.01

1.2

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.14

3.99

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

150

1.84

3.91

1.6

1.3

109.44

433.49

nmol/24h

0.79

150

(3019174) dRVVT (LA screen)

2.98

3.79

1.2

1.3

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.21

3.78

1.3

1.2

16.40

204.57

titre

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.70

3.75

2.9

1.8

0.69

0.58

ug/l

0.48

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.42

3.75

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

314

1.55

3.74

2.0

1.9

1.98

3.74

u/ml

0.93

103

(3009015) Lactate [Moles/volume] in Synovial fluid

2.78

3.74

1.2

6.60

5.23

mmol/l

0.43

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.46

3.74

1.5

1.8

—

(3030313) Adrenal Ab [Titer] in Serum

3.16

3.71

1.1

1.0

—

10.00

titre

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

4.35

3.64

2.2

—

(4281824) Cell count and differential, peritoneal fluid

150

535

1.41

3.62

1.2

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.70

3.59

1.1

1.3

733.37

78.15

mg/24h

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.21

3.57

1.1

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.21

3.57

1.0

1.3

0.06

0.12

u/ml

0.33

(3036312) Salmon IgE Ab [Units/volume] in Serum

3.05

3.52

1.0

0.42

3.64

u/ml

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.34

3.51

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

5.02

3.51

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.11

3.51

1.7

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

126

438

1.45

3.51

1.1

7.40

8.47

iu/ml

0.20

152

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.81

3.46

1.2

1.5

32.15

22.23

nmol/l

0.21

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

6.46

3.45

1.1

1.0

7.93

9.58

mmol/l

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

261

1.58

3.43

1.3

1.2

5.31

5.66

umol/l

0.31

230

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.21

3.34

1.6

1.3

0.18

0.17

nmol/l

0.04

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

269

1.55

3.24

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

164

1.72

3.23

1.8

1.7

74.29

141.74

au/ml

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.65

3.19

1.1

1.0

—

mmol/l

—

(3013336) Amino acids [Identifier] in Serum or Plasma

5.65

3.19

5.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

2.85

3.18

1.4

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

219

1.61

3.17

1.2

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.51

3.17

1.0

0.24

0.38

u/ml

—

(3034891) Synovial lining cells/cells in Synovial fluid

255

1.56

3.15

1.6

1.4

5.72

5.18

0.07

(3005011) Chlamydia sp Ab [Titer] in Serum

2.16

3.10

1.5

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.01

3.07

1.5

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.40

3.05

1.2

1.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

4.56

3.02

1.3

1.2

2.50

1.55

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.58

3.02

1.0

1.1

20.80

26.62

iu/ml

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.26

2.99

3.8

2.4

100.85

103.65

g/l

0.28

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

219

1.58

2.97

1.3

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.02

2.96

2.2

1.0

—

(3013762) Body weight Measured

5.02

2.96

1.0

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

3.06

2.93

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.06

2.93

3.8

2.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

301

1.49

2.91

1.1

1.0

—

(3036180) Methadone [Presence] in Urine

7.03

2.90

2.7

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

291

1182

1.24

2.90

1.1

1.0

5.53

5.32

u/ml

0.06

142

463

(3052592) Norovirus Ag [Presence] in Stool

1.98

2.89

1.5

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.00

2.85

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.26

2.84

1.7

1.5

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.30

2.82

1.0

1.1

—

(44806071) Cardiolipin IgM antibody measurement

2.16

2.80

1.0

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.34

2.79

2.7

3.3

0.43

0.40

u/field

0.08

(40758358) Immune stain study

4.52

2.75

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.59

2.73

1.4

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

165

1.64

2.73

1.2

1.3

—

(3017509) Phencyclidine [Presence] in Urine

2.05

2.68

1.7

1.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.96

2.63

1.1

1.0

74.56

82.03

ug/l

0.49

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

118

1.75

2.57

1.4

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

126

1.71

2.54

1.3

1.1

—

(4211845) Urine protein measurement

245

1.50

2.52

2.9

2.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

119

1.73

2.51

1.4

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

119

1.73

2.51

1.4

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

108

1.77

2.49

2.1

2.3

8.24

8.13

mmol/l

0.03

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.01

2.48

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

112

1.75

2.48

1.2

1.7

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.44

2.47

1.5

1.1

103.14

109.17

ug/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.84

2.46

1.1

1.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

338

1.41

2.45

1.4

1.2

432.78

411.70

u/l

0.05

320

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.60

2.45

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.10

2.43

1.3

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.23

2.43

1.1

1.0

0.02

0.04

u/ml

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.27

2.40

1.2

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.27

2.40

1.3

1.1

15.11

17.31

u/l

0.11

(3003740) Influenza virus B Ag [Presence] in Specimen

385

1643

1.18

2.37

1.1

—

(44786800) Granulocytes/Leukocytes in Body fluid

2.15

2.36

1.4

1.2

27.33

24.63

0.10

(3002523) Influenza virus A Ag [Presence] in Specimen

384

1641

1.18

2.33

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.91

2.26

3.6

2.8

—

(3012989) Citrate [Moles/time] in 24 hour Urine

4.39

2.19

1.3

1.1

1.94

1.83

mmol/24h

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.20

2.15

1.0

—

(3033086) Enterovirus Ab [Titer] in Serum

3.65

2.11

1.0

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.65

2.11

1.1

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

134

1.61

2.09

1.4

1.3

7.87

6.94

mmol/l

0.51

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.95

2.06

2.1

2.8

327.80

232.67

ug/l

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.35

2.06

1.4

1.2

305.47

313.53

umol/24h

0.06

(3002619) Bacteria identified in Specimen by Culture

108

1.67

2.02

1.2

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

3.90

2.00

1.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.35

1.96

1.0

1.2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.28

1.94

1.1

1.0

36.14

50.95

mg/l

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

125

1.61

1.94

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

270

1.40

1.89

1.2

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

111

1.63

1.85

1.6

1.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.22

1.83

1.1

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

418

0.71

1.83

1.7

1.3

0.53

0.54

e9/l

0.10

418

(3032641) Amino acids panel - Urine

5.02

1.82

1.8

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

2.08

1.81

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.01

1.76

1.1

74.67

80.36

titre

0.13

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

382

1681

1.14

1.68

1.5

1.4

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.91

1.64

1.8

1.3

—

(40762814) Titanium [Mass/volume] in Blood

1.72

1.64

2.6

2.7

3.31

3.51

ug/l

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

2.09

1.63

1.8

1.6

59.60

70.43

—

(40768800) Prostate Pathology biopsy report

415

1841

1.13

1.63

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

4.18

1.62

1.0

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

211

1.40

1.59

1.2

1.4

57.74

57.13

0.04

183

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

2.13

1.59

1.6

1.4

18.75

20.71

—

(3006462) Nitrate [Presence] in Urine

224

1.39

1.58

3.0

2.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.35

1.57

2.8

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.93

1.56

1.3

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.83

1.54

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.04

1.54

1.0

1.1

16.75

16.24

u/ml

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

122

1.52

1.50

1.3

1.2

368.57

30.01

mg/l

1.11

(3010937) Rubella virus Ab [Presence] in Serum

2.39

1.45

1.0

—

(36303858) Crystals [Presence] in Urine

3.59

1.44

1.0

—

(3016135) IgD [Mass/volume] in Serum

3.59

1.44

1.0

36.84

36.36

mg/l

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

3.59

1.44

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.59

1.44

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.59

1.44

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.59

1.44

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.59

1.44

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.59

1.44

1.0

2.3

27.44

47.50

umol/24h

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.59

1.44

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.59

1.44

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

128

523

1.23

1.39

2.7

2.2

31.98

29.78

mg/l

0.23

100

358

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.65

1.36

1.6

1.5

1.63

2.04

ug/l

0.22

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.26

1.34

1.2

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.26

1.34

1.0

—

(44813793) Dust mix specific IgE antibody measurement

108

435

1.25

1.34

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.08

1.31

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

119

1.48

1.27

2.1

2.4

99.76

92.38

ng/l

0.13

(4133840) Spirometry

220

1.32

1.17

1.1

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.09

1.12

1.5

1.4

608.24

349.82

nmol/l

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.15

1.10

8.3

10.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.51

1.05

1.0

1.2

—

(3024316) Viscosity of Plasma

1.88

1.05

1.4

1.8

1.31

1.86

mpas

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.51

0.99

1.0

1.2

1.57

1.24

u/ml

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

2.07

0.99

1.0

1290.29

199.88

u/l

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.32

0.95

2.0

1.1

365.00

420.38

mg/24h

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.84

0.91

1.1

1.0

0.18

0.22

u/ml

—

(3034614) HLA Ag [Interpretation]

2.15

0.90

1.3

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.15

0.90

1.2

1.1

184.67

228.60

nmol/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

224

1010

1.11

0.81

1.5

1.3

211.39

187.91

pmol/l

0.25

224

1010

(3018001) Oat IgE Ab [Units/volume] in Serum

1.73

0.77

1.0

0.24

0.12

u/ml

—

(4212803) Bone marrow aspirate examination

1.57

0.76

1.1

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.43

0.76

2.7

2.6

—

(3025130) Human papilloma virus identified in Specimen

160

711

1.13

0.75

1.9

1.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

117

509

1.15

0.75

1.0

1.1

1.50

2.62

u/ml

0.43

104

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.09

0.74

1.0

329.20

300.97

u/ml

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

117

1.33

0.72

1.1

1.2

—

17.89

u/ml

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.59

0.65

1.2

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

108

474

1.14

0.64

1.0

1.1

2.93

0.67

u/ml

0.43

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.39

0.62

1.1

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

113

499

1.14

0.62

1.1

0.90

2.78

u/ml

0.52

123

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.54

0.59

1.3

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

158

1.24

0.57

1.1

1.0

48.67

35.73

iu/ml

0.55

158

(3016031) Almond IgE Ab [Units/volume] in Serum

1.51

0.54

1.0

1.1

1.33

2.06

u/ml

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.60

0.50

1.1

28.56

33.31

mg/24h

—

(3009677) Dengue virus Ab [Presence] in Serum

1.53

0.49

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.52

0.48

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

388

1.13

0.46

1.3

1.1

8.70

8.98

mm/h

0.09

388

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.38

0.42

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.48

0.40

4.8

5.9

0.40

0.29

mmol/l

—

(3022475) Manganese [Moles/volume] in Blood

1.37

0.39

1.0

1.2

0.17

0.15

umol/l

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.51

0.37

1.0

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

1.43

0.36

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.43

0.36

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.36

1.3

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.30

0.36

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

772

3993

0.97

0.35

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.30

0.34

1.7

2.7

—

(3001729) Color of Synovial fluid

1.30

0.33

1.3

1.7

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.24

0.31

1.1

1.2

18.68

20.84

mmol/l

0.88

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.31

0.27

4.4

5.8

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.29

0.27

1.7

1.5

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

1.25

0.23

1.0

1.1

—

11057.50

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.17

0.18

1.4

1.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.19

0.16

1.1

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

353

1812

0.98

0.14

3.7

2.6

29.42

28.30

mg/l

0.22

238

1227

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

109

1.11

0.13

1.1

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

124

0.93

0.08

6.4

6.2

8.79

8.28

mmol/l

0.29

124

(3020650) Glucose [Presence] in Urine

306

0.97

0.06

2.0

1.4

0.10

0.06

estimate

0.27

306

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.06

0.05

1.0

1.1

3.66

15.74

u/ml

0.85

(3046861) Legionella sp Ag [Presence] in Urine

1.12

0.05

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.97

0.00

1.4

1.2

6.06

6.21

mmol/l

0.30

(44806420) Estimation of glomerular filtration rate

177

889

1.00

0.00

2.5

2.4

—

(3003577) Lead [Moles/volume] in Blood

1.01

0.00

1.4

1.6

0.15

0.50

umol/l

—

(3006598) pH of Arterial cord blood

0.91

-0.00

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.93

-0.00

1.1

2.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.92

-0.00

1.7

1.1

1.63

1.42

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_FACTO_INFLUENCI_HEALTH_STATUS_CONTACT_W_HEALTH_SERVI – Factors influencing health status and contact with health services

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Factors influencing health status and contact with health services

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Factors influencing health status and contact with health services (Z21_FACTO_INFLUENCI_HEALTH_STATUS_CONTACT_W_HEALTH_SERVI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints